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ABSTRACT 
The B12 coenzymes are required cofactors for at least 15 different enzymes that are 
widely distributed in nature and are essential for human health. Characterizing enzymes in 
each step of vitamin B12 metabolism in humans will provide important information for 
human B12-related disease diagnosis and therapy. Human ATP:cob(I)alamin 
adenosyltransferase (hATR) catalyzes the final step in the conversion of vitamin B12 into the 
active coenzyme, adenosylcobalamin. Inherited defects in this gene result in a rare but life-
threatening disease, methylmalonyl aciduria. We conducted a random mutagenesis of the 
hATR coding sequence. Fifty-seven missense mutations were isolated mapping to 30 
positions, 25 of which had not previously been shown to impair enzyme activity. Kinetic 
analysis and in vivo tests for enzyme activity were performed on the hATR variants, and 
mutations were mapped onto a hATR structural model. These studies functionally defined the 
hATR active site and tentatively implicated three amino acid residues in facilitating the 
reduction of cob(II)alamin to cob(I)alamin which is a prerequisite to adenosylation. 
Human cannot synthesize coenzyme B12 de novo but assimilate B12 complex precursors, 
which are only from certain prokaryotes. The biosynthesis of B12 has been studied extensively 
in Salmonella enterica, however, the function of PduX gene involved in B12-dependent 
propanediol degradation was still unknown. In vitro test including 31P NMR spectroscopy 
and enzyme assays established that purified PduX-His6 catalyzed the conversion of L-
threonine and ATP to L-threonine-O-3-phosphate and ADP. A series of in vivo growth 
studies showed that PduX is an L-threonine kinase used for AdoCbl synthesis. The PduX 
enzyme belongs to GHMP kinase family by sequence similarity. Kinetic analysis indicated an 
viii
ordered ternary complex mechanism in which ATP is the first substrate to bind. The lack of 
obvious solvent pH and isotope effects indicated that proton transfer is unlikely to be 
involved directly in the rate determining step of catalysis. Based on a multiple sequence 
alignment of PduX homologues and other GHMP family members, 14 PduX variant were 
constructed by site-directed mutagenesis. Comparison of the Circular Dichroism spectra and 
kinetic properties of the PduX variants to those of the wild-type enzyme functionally defined 
the L-threonine kinase active site. 
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CHAPTER 1 GENERAL INTRODUCTION 
Introduction 
Vitamin B12 is the most chemically complex of all the vitamins. The structure of B12 is 
based on a corrin ring, which is similar to the porphyrin ring found in heme, chlorophyll, and 
cytochrome. Biosynthesis of the basic structure of vitamin B12 can only be accomplished by 
certain bacteria and archaea, but conversion between different forms of the vitamin can be 
accomplished in the human body. Vitamin B12 is important for the normal functioning of the 
brain and nervous system, and for the formation of blood. It is normally involved in the 
metabolism of every cell of the body, especially affecting DNA synthesis and regulation, as 
well as fatty acid synthesis and energy production. 
Vitamin B12 is naturally found in foods of animal origin including meat and milk 
products. Animals, in turn, must obtain it directly or indirectly from bacteria, and these 
bacteria may inhabit a section of the gut which is posterior to the section where B12 is 
absorbed. Vitamin B12 can be supplemented in healthy subjects by liquid, strip, nasal spray, 
or injection and is available singly or in combination with other supplements. 
Literature Review 
I. History of Vitamin B12 
The early history of B12 belongs entirely to medicine. In 1824, Combe recorded the first 
tentative description of pernicious anemia and mentioned that it could be related to a disorder 
of digestive system (1). The next hundred years witnessed a slow but steady increase in our 
knowledge of the signs of the disease and methods of diagnosis but a total absence of any 
advance in the treatment of the disease, which remained incurable and was usually fatal. 
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Then in 1925, Whipple showed that the regeneration of red blood cells in dogs made anemic 
by bleeding was stimulated by a diet containing liver, and in 1926 Minot and Murphy in 
Boston reported a remarkable improvement in patients fed a diet of raw liver. This clue 
started the search for the “liver factor” or “anti-pernicious anemia factor”, which last over 
twenty years. Whipple, Minot and Murphy were rewarded the Nobel Prize in Physiology and 
Medicine in 1934. 
After the original impetus received from medicine in 1926 the main stimuli have come 
from the fields of microbiology and biochemistry, in which one can discern four successful 
and overlapping phases of activity (2). 
The first phase (from 1926 to 1948) ended with successful isolation of B12 in 1948. The 
isolation of crystalline vitamin B12 was reported independently by two teams in 1948, first by 
Folkers and his colleagues at Merck Laboratories in the U.S. (3). They isolated a red 
crystalline compound from liver. This compound, designed as vitamin B12, was found to 
produce hematological responses in three patients with pernicious anemia. Almost 
simultaneously, Smith and Parker at Glaxo Laboratories in the U.K. reported the purification 
of an anti-pernicious anemia factor from both nonproteolyzed and papain-treated liver (4, 5). 
In the following year, Ellis, Petrow and Snook at British Drug Houses in the U.K. reported 
the isolation of the crystalline anti-pernicious anemia factor from liver and showed its 
electronic spectrum (6). 
The second phase (from 1948 to 1955) involved the development of methods for the 
large scale production B12 by fermentation techniques through the screening and selection of 
microorganisms (7, 8). It soon became clear that B12 was only one of a family of corrinoids 
occurring in nature. Immediately following the isolation crystalline vitamin B12, studies were 
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initiated in several laboratories to determine the structure of this new vitamin. Early analysis 
showed that it contained both cobalt and phosphate. Brink carried out the first elemental 
analysis of the vitamin, yield a result of C61-64H86-92N14O13PCo, remarkably close to the 
now-known composition, C63H88N14O14PCo (9). The elucidation of the structure of vitamin 
B12 and the identification of the unique corrin ring containing four reduced pyrrole rings with 
a direct connection between the A and D rings finally accomplished by X-ray 
crystallographic analysis in the laboratory of Hodgkin in 1954 and the next few years (10). 
The third phase (from 1950 to 1962) may be considered as answering the question 
“which corrinoids occur in nature” (7, 8, 11). The most important single discovery under this 
heading was the isolation of the so-called “coenzyme” form of a corrinoid by Barker and his 
associates in California in 1958 (12). They reported a charcoal-absorbable substance was 
required as a cofactor for the glutamate mutase reaction and this yellow-orange cofactor was 
found to be light-sensitive. The relation between the cofactor and vitamin B12 was recognized 
when Weissbach noted the similarity between the spectra of vitamin B12 and the coenzyme in 
alkaline cyanide solution (13). In coenzyme form of vitamin B12, the cyanide group is 
replaced by adenosine or methyl group. X-ray analysis, carried out by Professor Dorothy 
Hodgkin and her associates at Oxford, has played a very important part in the development of 
vitamin B12 chemistry. Their work revealed the presence of two structures hitherto unknown 
in nature, namely the corrin ring which is present in all corrinoids and cobalt-carbon bond 
which is present in the coenzymes (14). Professor Hodgkin’s elegant work in applying X-ray 
diffraction techniques to such complicated molecules was rewarded with the Nobel Prize for 
Chemistry in 1964. 
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Barker’s discovery of the coenzyme can also be considered as the start of the fourth 
phase of activity (from 1958 to now and still continuing), that of enzymatic reactions, in 
which one aims to answer the question “what reactions do corrinoids catalyze in conjunction 
with proteins and how”. To date, several adenosylcobalamin-dependent enzyme have been 
isolated including four carbon-skeleton mutases (glutamate mutase, methylmalonyl CoA 
mutase, 2-methyleneglutarate mutase, and isobutyryl CoA mutase), four eliminases 
(dioldehydrase, glycerol dehydrase, ethanolamine-ammonialyase, and ribonucleotide 
redutase), and three amino mutases (L-β-lysine mutase, D-α-lysine mutase and ornithine 
mutase). Methylcobalamin and methylcorrinoids have been shown to be cofactors for 
methionine synthase and for the synthesis of acetone and methane in several anaerobic 
bacteria and archaea (15-18). 
The advances made during the past 60 years in B12 research have been phenomenal and 
are certain to continue. In the short future, we can expect that the three-dimensional structure 
of all the B12-dependent enzymes and binding proteins will be solved. At that time the 
mechanism of these enzymes will also be established. 
II. Chemistry of Vitamin B12 
The various derivatives of vitamin B12 belonging to the series of cobalamim are cobalt 
tetrapyrrole complexes having the structure shown on Figure 1.1. The central cobalt atom is 
coordinatively bound to the four nitrogen of the corrin ring, one of these bearing a negative 
charge. Attached to a carbon of the corrin ring is a nucleotide side chain terminated by a 
5,6-dimethylbenzimidazole group (DMB), which may act as an axial ligand toward the cobalt 
atom. The side chain bears an additional negative charge on the phosphate group down to 
low pH values. Cobalamin complexes in which the DMB is bound to the cobalt atom are 
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usually named base-on forms, whereas if such coordination is absent or replaced by an 
exogeneous ligand the designation base-off is used. Cobinamides are obtained by hydrolytic 
cleavage of the nucleotide side chain at the phosphate group. The side chain was reduced, 
and then lost its potential liganding ability toward the cobalt atom. Complexes in which the 
side chain still possesses the α-D-ribofuranose 3-phosphate residue but not necessarily the 
terminal 5,6-dimethylbenzimidazole, which may be replaced by other imidazolic structures, 
are named cobamides. The various cobamides, cobalamins, and cobinamides differ one from 
the other by the nature of the axial ligands in the lower and upper positions: water, OH-, CN-, 
alkyl carbanions, giving rise respectively to aquo, hydroxo, cyano, and alkyl cobalamins (19). 
The cobalt atom in cobalamins and cobinamides can exist under three main formal 
oxidation states, Co(III), Co(II), Co(I) (Figure 1.2): which display quite different chemical 
properties. Roughly speaking, Co(III) appears as an electrophile, Co(II) as a radical, and Co(I) 
as a nucleophile. Oxidoreductive conversions between the three oxidation states are thus of 
key importance in the chemistry of vitamin B12. When the formal oxidation state of the cobalt 
atom decreases, its coordination number tends to decrease accordingly. In the 
thermodynamically predominating forms, the coordination number is generally 6 (two axial 
ligands) for Co(III), 5 (one axial ligand) for Co(II), and 4 (no axial ligand) for Co(I). In B12 
electrochemistry, electron transfer is therefore expected not to be a simple outer-sphere 
process. It is generally accompanied by the expulsion of one ligand when going to a lower 
oxidation state and by the formation of a coordination bond upon increasing the oxidation 
state. On the other hand, according to the presence of potential axial ligands in the reaction 
medium, several forms of a given oxidation state may coexist and compete in reduction or 
 6
oxidation processes. The electrochemistry of B12 derivatives under both its thermodynamic 
and kinetic aspects is thus anticipated to depend heavily upon trans-ligandation factors. 
The nomenclature for vitamin B12 is complex. The rules for naming complete molecules 
and precursors have been published by the Commission on Biochemical Nomenclature (CBN) 
of the International Union of Pure and Applied Chemistry (IUPAC) and revised by the 
International Union of Biochemistry (IUB) (20). For the reader’s benefit, I highlight below 
terminology used in this thesis. 
Corrinoids. Molecules containing the cobalt-containing cyclic tetrapyrrole known as the 
corrin ring. 
Incomplete corrinoids. Corrinoids lacking the lower (Coα) axial ligand base. 
Cobamide (Cba). A complete corrinoid, that is, a corrinoid containing the nucleotide 
loop. The name of the Cba depends on the nature of the lower ligand. 
Cobalamin (Cbl). The Cba whose lower (Coα) ligand base is 
5,6-dimethylbenzimidazole (DMB). 
Adenosylcobamide (AdoCba). The coenzymic form of a Cba whose lower (Coα) ligand 
is not DMB. 
PseudoAdoCba. The coenzymic form of AdoCba with adenine as the lower (Coα) 
ligand. 
Vitamin B12, or cyanocobalamin. Cbl with a cyano group as the upper (Coβ) ligand. 
Coenzyme B12 or AdoCbl. Cbl with 5’-deoxyadenosine (Ado) as the upper (Coβ) ligand 
and DMB as the lower (Coα) ligand. 
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α-5,6-Dimethylbenzimidazole-ribosyl-5’-phosphate (α-ribazole-P). The nucleotide 
loop consisting of the DMB attached to ribose-5’-P. The N-glycosidic bond in this nucleotide 
is in the alpha configuration. 
III. Biosynthesis of Vitamin B12 
Many authors have suggested that B12 was synthesized prebiotically (21) and may have 
been important to catalysis in the “RNA world.” In some bacteria, B12 biosynthesis begins 
with an aminoacyl-tRNA molecule, and an RNA molecule may play an intimate role in 
regulating expression of biosynthetic and transport genes. Porphyrins such as those 
contributing to the B12 structure have been synthesized nonenzymatically in so-called 
primitive earth experiments (22). The cobalamin biosynthetic pathway, and the pathways 
common to heme, chlorophyll, and siroheme synthesis, may reflect the evolution of energy 
metabolism (Figure 1.3). It seems likely that this pathway first evolved to produce B12, a 
view supported by considering the structure of uroporphyrinogen III (UroIII), the common 
precursor of heme, siroheme, chlorophyll, and cobalamin. UroIII is asymmetric in the sense 
that one of the porphyrin rings is reversed with respect to the others. The reversal may be 
important for the carbon elimination or ring contraction that occurs later in cobalamin 
synthesis. This arrangement indicates that the entire pathway developed initially to serve B12 
synthesis and later added the branches to siroheme, heme, and chlorophyll. It is suggested 
that the initial significance of B12 was to support anaerobic fermentation of small molecules 
by generating internal electron sinks (23). Later, siroheme allowed inorganic molecules to be 
used as electron acceptors, which is seen in siroheme’s modern role as a cofactor for sulfite 
and nitrite reductases. Still later arrivals may have been chlorophyll and heme, which allowed 
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biological formation of molecular oxygen and use of oxygen as a respiratory electron 
acceptor. 
According to a widely accepted historical view, B12 synthesis is restricted to some 
Bacteria and Archaea. Many animals, including humans, and protests require B12 but 
apparently do not synthesize it. Plants and fungi are thought to neither synthesize nor use B12 
in their metabolism. Figure 1.4 superimposes the distribution of B12 on a prominent view of 
the evolutionary relationships between these life-forms. The distribution pattern, even with 
some exceptions, raises questions regarding the biochemical significance of B12 and the 
metabolic differences among life-forms that allow some to escape the need for B12. Such 
questions should be kept in mind as we review the general nature of B12-dependent reactions. 
 Vitamin B12 is manufactured by bacteria and archaea via two alternative routes that 
differ primarily in the early stages that lead to the contraction of the macrocycle and excision 
of the extruded carbon molecule and its attached methyl group. One pathway incorporates 
molecular oxygen into the macrocycle as a prerequisite to ring contraction, and has 
consequently been termed the aerobic pathway. The alternative, anaerobic, route takes 
advantage of a chelated cobalt ion, in the absence of oxygen, to set the stage for ring 
contraction. The intermediates of the aerobic biosynthetic route from UroIII to 
adenosylcobalamin have been determined by the isolation of the genes from Pseudomonas 
denitrificans (cobA-cobW) and the assignment of the functions of the encoded enzymes based 
on their catalytic activity (Figure 1.5) (24). Genes encoding proteins involved in the 
biosynthesis of cobalamin by the alternative anaerobic pathway have been isolated and 
sequenced from bacteria such as Salmonella typhimurium (25), Bacillus megaterium (26) and 
Propionibacterium freudenreichii (shermanii) (27) and, while catalytic activity has been 
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determined experimentally for a few of the gene products, most of their functions have been 
derived on the basis of sequence similarities. 
The biosynthetic route to adenosylcobalamin from its five-carbon precursor, 
5-aminolaevulinic acid (ALA) may be divided into three sections: (1) the biosynthesis of 
UroIII from ALA, which is shared by both pathways (Figure 1.5) ; (2) the conversion of 
UroIII into the ring-contracted, deacylated intermediate (precorrin 6 or cobalt-precorrin 6), 
wherein lies the primary differences between the two pathways (Figure 1.5) ; and (3) the 
transformation of this intermediate to adenosylcobalamin (Figure 1.6). 
 1. Biosynthesis of UroIII. UroIII is an intermediate not only of vitamin B12 but also of 
haem, sirohaem, chlorophylls and factor F430. It is biosynthesized from ALA utilizing the 
enzymes ALA dehydratase (HemB), porphobilinogen deaminase (HemC) and UroIII 
synthase (HemD). The most recent advance in elucidation of the biosynthesis of UroIII has 
been the unveiling of the crystallographic structure of human UroIII synthase (28), which 
revealed an interesting barbell-shaped conformation, but which did not shed any further light 
on the mechanism of the enzyme, due to the lack of a structure with bound substrate or other 
ligand. The absence of any essential conserved residues, however, as revealed by 
site-directed mutagenesis, suggests that the function of the enzyme is to hold the substrate in 
the correct conformation, with catalysis then proceeding spontaneously. 
 2. Conversion of UroIII into precorrin 6 or cobalt-precorrin 6. In the aerobic 
pathway, this process, resulting in the formation of precorrin 6, requires five 
S-adenosyl-L-methionine-dependent methyltransferases for the introduction of six methyl 
groups and is characterized by the incorporation of molecular oxygen by a monooxygenase. 
First, precorrin 2 is formed from UroIII by methylation at C-2 and C-7 by CobA, followed by 
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methylation at C-20 by CobI to give precorrin 3. Incorporation of O2, also at C-20, and the 
concomitant formation of a γ-lactone, both catalysed by CobG, to yield precorrin 3 
hydroxylactone are prerequisites for contraction of the macrocycle. Ring contraction is then 
triggered by methylation at C-17 by CobJ to give precorrin 4, featuring amethylketone, 
derived from C-20 and its attached hydroxy and methyl groups, pendant to C-1. Precorrin 5 is 
formed by methylation of C-11 by CobM, and then, in the final step to form precorrin 6, the 
methylketone is lost as acetic acid upon methylation of C-1 by CobF. 
The anaerobic pathway, resulting in cobalt-precorrin 6 rather than precorrin 6, also 
requires five methyltransferases, and is distinguished by the early incorporation of cobalt into 
the macrocycle. The biosynthesis of precorrin 2 is the same as in the aerobic pathway. After 
the synthesis of precorrin 2, the anaerobic route diverges from the aerobic route with the 
chelation of cobalt into the macrocycle to give cobalt-precorrin 2. In the anaerobic pathway, 
cobalt-precorrin 2 is methylated at C-20 by CbiL to afford cobalt-precorrin 3. The next 
known intermediate in the anaerobic pathway is cobalt-precorrin 4. CbiH is responsible for 
addition of a methyl group at C-17, which, as in the aerobic pathway, triggers contraction of 
the macrocycle. In contrast with precorrin 4 of the aerobic pathway, however, 
cobalt-precorrin 4 bears an unopened δ-lactone instead of a methylketone. Although the next 
intermediate of the anaerobic pathway, corresponding to precorrin 5 (cobalt-precorrin 5), has 
yet to be isolated, the C-11 methyltransferase is believed to be CbiF, based on its identity 
with CobM. The conversion of cobalt-precorrin 5 into cobalt-precorrin 6 requires opening of 
the δ-lactone ring, excision of acetaldehyde and C-1 methylation. Exchange with water in the 
carboxy group of the ring A acetate results from hydration during opening of the δ-lactone, 
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and the oxygen of the acetaldehyde is derived concomitantly from the ring A acetate during 
this process. 
3. Conversion of precorrin 6 or cobalt-precorrin 6 into adenosylcobalamin. The 
known pathway and enzymes necessary for the conversion of precorrin 6 into 
adenosylcobalamin in the aerobic pathway are shown in Figure 1.6. The structures of the 
intermediates of the anaerobic pathway between cobalt-precorrin 6 and adenosylcobalamin 
are believed to the same as those of the aerobic pathway, with the exception that, since the 
cobalt ion is already in place, dihydro-precorrin 6, precorrin 8 and hydrogenobyrinic acid are 
replaced with the corresponding cobalt complexes. Thus, in the anaerobic pathway, 
hydrogenobyrinic acid is replaced by cobyrinic acid, which then is the substrate for 
bisamidation to afford cob(II)yrinic acid a,c-diamide. All of the ensuing intermediates are 
identical in the aerobic and anaerobic pathways. 
4. Control of the cob/pdu Regulon. The cob operon (encoding B12 synthetic enzymes) 
maps adjacent to the pdu operon, which encodes enzymes for propanediol degradation. The 
two operons are both induced by propanediol using a single regulatory protein. These results 
indicate that the main role of B12 in S. typhimurium is in supporting catabolism of 
propanediol. Two global regulatory systems (Crp/Cya and ArcA/ArcB) affect inducibility of 
the cob and pdu operons (29-31). Both operons are activated aerobically and anaerobically by 
Crp protein and anaerobically by ArcA protein. Maximum inducibility is seen during 
anaerobic respiration of a poor carbon source; under these conditions the Crp and ArcA 
proteins act additively. The control of the regulon depends on five promoters, all located in 
the central region between the cob and pdu operons; four of these promoters are activated by 
the PocR protein (32). 
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The current model for control of this system includes the following features (Figure 1.7): 
The cob and pdu operons are transcribed divergently from promoters indicated at the far right 
and left in the figure. These promoters are activated whenever both the PocR protein and 
propanediol are present. Global control of the two operons is exerted by varying the level of 
PocR protein. The pocR gene is transcribed by three promoters controlled both by global 
regulatory proteins and by autoinduction (32). The shortest transcript (from Ppoc) appears to 
be regulated only by Crp/cAMP. The P2 transcript clearly is autoregulated by PocR and, in 
addition, requires the ArcA protein, which signals a reduced cell interior (32). Control of the 
P1 promoter is less certain but may involve either the Fnr protein (responding to a reduced 
cell interior) or the Crp protein (responding to a shortage of carbon and energy) in addition to 
the PocR activator. The involvement of these proteins in control of P1 is based heavily on the 
presence of appropriate binding sites upstream of that promoter.  
It is proposed that the regulon has three states (23). In the off condition (during aerobic 
growth on glucose), all promoters are at their lowest level; PocR protein is produced by the 
basal expression levels of promoters P1, P2, and Ppoc. Cells enter a standby state when they 
grow under any set of global conditions appropriate for induction, but without propanediol. 
These conditions include aerobic growth on a poor carbon source and/or growth without 
oxygen. These conditions stimulate expression of both the PduF transporter and the PocR 
regulatory protein, but the cob and pdu operons remain uninduced. The standby expression of 
PocR can occur from the Ppoc and/or the P1 promoter without inducer. The two proteins 
induced in the standby state (PduF and PocR) are those needed to sense propanediol. If 
propanediol appears, the P1 and P2 promoters are induced, increasing the level of PocR 
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protein and placing the system in the on state. The resulting high level of PocR/propanediol 
complex induces expression of the cob and pdu promoters. 
IV. Functions of Vitamin B12 
The original significance of B12, and its remaining primary role in many modern bacteria, 
may support fermentation of small molecules by catalyzing molecular rearrangements that 
generate both an oxidizable compound and an electron sink for use in balancing redox 
reactions. In enteric bacteria, this role is seen in the B12-dependent degradation of 
ethanolamine, propanediol, and glycerol (Figure 1.8). In these reactions, the B12-mediated 
rearrangement generates an aldehyde that can be oxidized and provide ATP; the oxidation 
reactions can be balanced by reducing a portion of the aldehyde to an alcohol, which is 
excreted. The B12-dependent reaction forms the reducible compound by a rearrangement, 
essentially an internal redox reaction. In nonenteric bacteria, the B12-dependent amino 
mutases (specific for glutamic acid, lysine, leucine, or ornithine) catalyze mechanistically 
similar reactions that support fermentation of these amino acids.  
Thus the earliest use of B12 may have been to support anaerobic, fermentative growth at 
the expense of small molecules. Additional reactions (such as methionine synthesis and 
nucleotide reduction) appeared as secondary uses. After oxygen and aerobic respiration 
appeared on earth, many organisms no longer needed to perform fermentations and lost some 
of their original enzymatic capabilities. The secondary uses such as methyl transfer remained 
important and enforced a continued requirement for B12. Obligate aerobes and animals appear 
to require B12 to perform these nonfermentative functions. In humans, two B12-dependent 
reactions are known. Methionine synthetase, a methyl transferase, is presumed to be 
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important primarily in recycling folate and secondarily in producing methionine (33). Methyl 
malonyl CoA mutase may serve mainly to remove toxic products of lipid breakdown (34). 
1. B12-Dependent Reactions in Enteric Bacteria 
Propanediol Dehydratase, which converts 1,2-propanediol to propionaldehyde, is 
found in virtually all enteric bacteria tested except Escherichia coli (35, 36). Some bacteria 
ferment propanediol by oxidizing a portion of the propionaldehyde to provide carbon and 
energy while reducing the rest to provide an electron sink for balancing redox reactions (37). 
In Salmonella species this process provides energy but no carbon source. Propanediol is 
encountered frequently by bacteria, because it is produced during anaerobic catabolism of the 
common methylpentoses, rhamnose and fucose. 
Ethanolamine Ammonia Lyase converts ethanolamine to acetaldehyde and ammonia 
(38, 39). Under some conditions, the produced acetaldehyde can serve as a carbon and energy 
source via acetyl-CoA. Ethanolamine is frequently encountered in nature as part of common 
lipids, phosphatidyl ethanolamine and phosphatidyl choline. 
Glycerol Dehydratase converts glycerol to β-hydroxypropionaldehyde, which can be 
reduced to 1, 3-propanediol (40, 41). This reaction balances the reducing equivalents 
generated by glycerol dehydrogenase. Glycerol dehydratase is common in enterics but is 
absent from both Salmonella spp. and E. coli (35). 
Epoxyqueuosine Reductase performs the last step in formation of the hypermodified 
tRNA base, queuosine, found in tRNAtyr, tRNAhis, tRNAasn, and tRNAasp (42). The 
modified base is not essential for bacterial growth under laboratory conditions (43). Although 
the final reaction has been reported to require B12 (42), it proceeds in anaerobically grown E. 
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coli cells, which do not make B12 (35). We suggest that the reaction may be stimulated by B12, 
perhaps indirectly, in vivo, but can be catalyzed without this cofactor. 
2. B12-Dependent Reactions in Human 
Methionine Synthase transfers a methyl group from methyltetrahydrofolate to 
homocysteine as the final step in synthesis of methionine and is probably the best-known 
B12-dependent reaction (Figure 1.9) (44, 45). During primary turnover (red arrows), a methyl 
group is transferred from CH3-H4folate to the enzyme-bound cob(I)alamin cofactor, forming H4-folate 
and methylcobalamin. Methylcobalamin is then demethylated by Hcy, forming methionine and 
regenerating cob(I)alamin. In reactivation (green arrows), cob(II)alamin is reduced by one-electron 
transfer from flavodoxin and the resulting cob(I)alamin is methylated by AdoMet. The lack of this 
reaction underlies many aspects of human B12-deficiency disorders (33). In Salmonella spp. 
and in E. coli, the B12-dependent methyl transfer reaction is catalyzed by the MetH enzyme, 
and both organisms produce a second enzyme (MetE) that can catalyze the same reaction 
without B12 (44, 46-48). The MetH enzyme is used preferentially when B12 is available; the 
alternative MetE enzyme is induced in response to accumulated homocysteine when the 
MetH enzyme is inactive (49). In bacteria with an alternative, B12-independent enzyme, 
methionine synthesis is unlikely to be the major selective force maintaining B12 synthetic 
capacity. 
Methylmalonyl-CoA Mutase interconverts (R)-methylmalonyl-CoA and succinyl-CoA 
(Figure 1.10) (50). The first step, homolysis of the Co-carbon bond, is observed upon 
addition of substrate and leads to the formation of cob-(II)alamin and the deoxyadenosyl 
radical (step i). This is followed by hydrogen atom (H-atom) abstraction from the substrate, 
methylmalonyl-CoA, by the deoxyadenosyl radical to generate a reactive primary substrate 
 16
radical (step ii). Rearrangement generates a secondary product-centered radical (step iii). 
Finally, a second H-atom transfer from deoxyadenosine yields product (step iv), and 
recombination of the cofactorcentered radical pair (step v) completes a turnover cycle. 
Higher animals require the mutase for degradation of odd-chain-length fatty acids and certain 
branched-chain amino acids (Figure 1.11). In humans, mutase deficiency results in an often 
fatal methylmalonic acidemia (34), and in certain neuropsychiatric symptoms. These 
symptoms may result from synthesis of abnormal myelin lipids in the presence of 
accumulated propionyl- and methylmalonyl-CoA (33, 51). In certain bacterial fermentations, 
succinate is converted to propionate via the mutase rather than being excreted. This pathway 
allows conservation of a biotin-activated CO2 that is derived from succinate. In Streptomyces 
cinnamonensis, the mutase may also play a role in polyketide antibiotic synthesis (52). 
3. Other Prominent B12-Dependent Reactions 
Acetyl-Coa Synthesis: In many anaerobic bacteria, methyl-corrinoids are involved in 
acetyl-CoA synthesis via the Wood/Ljungdahl pathway (53-55). In this pathway, a methyl 
group is transferred from methyltetrahydofolate via a methyl-corrinoid/iron sulfur protein to 
CO-dehydrogenase, which synthesizes acetyl-CoA from this methyl group, CO, and 
coenzyme A (56). A corrinoid plays an analogous role in the energy-yielding metabolism of 
acetogenic bacteria (53), which synthesize acetate from 2 CO2 as a means of generating a 
terminal electron sink. 
Methyl Transfer in the methane-Producing Archaea: Methyl-corrinoids are essential 
for formation of methane by the strictly anaerobic methane-producing Archaea (54). 
Corrinoid proteins play a role in the transfer of methyl groups from methanogenic substrates 
to the thiol group of the methanogen-specific cofactor, coenzyme M. Different enzymes 
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mediate methyl transfer from alternative methanogenic substrates such as acetate (57), 
methylamines (58), methanol, pyruvate (59) and methyltetrahydromethanopterin, an 
intermediate of methanogenesis from formate and CO2 (60). The latter reaction is analogous 
to methionine synthesis in that the methyl group is transferred from an intermediate pterin 
which is a heterocyclic compound composed of a pyrazine ring and a pyrimidine ring to a 
thiol group via methyl-B12 (60). Considerable energy is released by transfer of a methyl 
group to coenzyme M from methyltetrahydromethanopterin (54, 61). The energy of the 
transfer to coenzyme M can be recovered by coupling the methyl transfer to extrusion of a 
sodium ion, which eventually leads to generation of a proton motive force (62). The 
transferase that achieves this feat is an integral membrane protein (63) composed of eight 
different subunits (61). 
Ribonucleotide Reductases generate the deoxyribonucleotides needed for DNA 
synthesis. Four classes of this reductase are known, each with a different cofactor 
requirement and quaternary structure; this variability is unusual for enzymes that play such 
key metabolic roles. The Ado-B12-dependent reductases belong to Class II and are found 
primarily in microorganisms (64, 65). The reaction mechanism and active site structure of the 
corrinoid-dependent reductase appears remarkably similar to that of the Ado-B12-independent 
Class I enzyme of E. coli (66). In this reductase, Ado-B12 serves as a free-radical generator. 
Other reductases form radicals by alternative means (67). 
Degradation of β-Hydroxy Ethers and β-Hydroxy Amines: Corrinoids are implicated 
in the anaerobic degradation of several compounds thought to be generally recalcitrant to 
degradation in the absence of oxygen. The compounds include polyethylene glycol (68), 
triethanolamine (69), and possibly phenoxyethanol (70). The significant chemical feature of 
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these compounds is a hydroxyl group β to an ether, a tertiary amine, or a secondary amine. 
These reactions are related to those catalyzed by diol dehydratases in that they are 
intramolecular redox reactions that involve the migration of a hydroxyl group. 
V. Vitamin B12-Related Diseases 
 Till today, there are only two known B12-dependent reaction in the human body: 
methionine synthase and methylmalonyl-CoA mutase. Thus, disorders of cobalamin transport 
and metabolism (Figure 1.12), whether inherited or acquired, manifest themselves as 
deficiencies in the activities of one or both of these enzymes and lead to accumulation in 
blood and urine of one or both of the substrates, homocysteine and methylmalonyl-CoA, 
respectively. The pathophysiology of these conditions varies with the severity and nature of 
the lesions and results from both the effects of substrates accumulation and products 
deficiency. From such studies, the following three subclasses of cobalamin disorders 
emerged: those resulting (i) in combined defects in MeCbl and AdoCbl synthesis (cblF, cblC, 
and cblD), (ii) in an isolated defect in MeCbl synthesis (cblD-variant 1, cblE, and cblG), and 
(iii) in an isolated defect in AdoCbl synthesis (cblD-variant 2, cblA, and cblB). The mut locus 
encodes methylmalonyl-CoA mutase. An additional locus, cblH, originally described as 
causing an isolated deficiency of methylmalonyl-CoA mutase (71), is now believed to be 
cblD-variant 2 (72). 
 Uptake and Transport of B12. Cobalamin is a water-soluble vitamin and at 
physiological levels of intake (1–5 µg/day) is unable to traverse the plasma membrane 
unaided. Three B12 binding proteins, intrinsic factor, haptocorrin, and transcobalamin II, bind 
B12 with great avidity and mediate its uptake and transport (73). Intrinsic factor is a secretory 
glycoprotein that binds B12 in the small intestine and in complex with a specific receptor, 
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cubulin, located on the brush border of enterocytes (73). Haptocorrin is a salivary 
glycoprotein that binds B12 with higher affinity than intrinsic factor at the acidic pH of the 
stomach and liberates the cofactor in the proximal small intestine upon being digested by 
pancreatic enzymes. B12 emerges from these cells into the portal circulation in complex with 
transcobalamin II (74). Haptocorrin is also found in the serum where it is derived from 
leukocytes. It appears to function as a major storage protein for cobalamin and may play a 
role in removal of degraded derivatives (75). All three proteins exhibit a very high affinity 
for B12 with Kd values for aquocob(III)alamin of 1 pM (intrinsic factor), 0.01 pM 
(haptocorrin), and 5 fM (transcobalamin II) measured at pH 7.5 and 20 °C (76). The pathway 
(Figure 1.13) involves a series of binding proteins in different compartments and specific 
receptors for the transport of these proteins and the associated cobalamin into or across cells. 
The pathway takes advantage of changes in binding constants to provide both directionality 
and efficiency to the transport process, as cobalamin and its transport proteins are exposed to 
environments of different pH in the gastrointestinal system and subcellular organelles. 
 Inherited Defects Affecting Both AdoCbl and MeCbl Synthesis. B12 is ferried to cells 
with a very high affinity transporter, transcobalamin II, which binds to a specific receptor on 
the cell surface (77). This complex is endocytosed and delivered to the lysosome (Figure 
1.12). The cblF class of mutations impairs egress of B12 from the lysosome and leads to the 
accumulation of the cofactor in this compartment (78). The affected gene in cblF patients 
remains to be identified. 
The function lost or impaired in cblC patients was first suggested to be a cytoplasmic 
reductase that reduces cob(III)alamin to cob(II)alamin (79). In fact cob(III)alamin reductase 
activities associated with the microsomal and mitochondrial membranes that exhibited 
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diminished activity in cblC (and cblD) cell lines have been reported (80). However, both 
locations seem improbable for delivery of the resulting cob(II)alamin to the target 
cytoplasmic and mitochondrial matrix enzymes, methionine synthase and 
adenosylltransferase (that synthesizes AdoCbl), respectively. It is possible that a nonspecific 
reductase activity was measured in these studies since the redox potential for the 
cob(III)alamin/cob(II)alamin redox couple is relatively high, making this a relatively facile 
reduction. The gene responsible for methylmalonic aciduria and homocystinuria, of the cblC 
class has been identified recently (81) and based on its sequence, does not appear to be a 
reductase. Alternatively, an NADPH and FAD-dependent β-ligand transferase function has 
been ascribed to the cblC (or cblD) gene product that catalyzes the reductive exchange of the 
aquo or cyano substituent at the upper orβ-axial position with glutathione to generate 
glutathionyl-cobalamin (80). However, the presence of glutathionyl-cobalamin in cells has 
not been established unequivocally since under conditions used for isolation (80), detection 
of sulfitocobalamin (a breakdown product of glutathionyl-cobalamin), may be expected. 
Furthermore, the uncatalyzed conversion of aquocobalamin to glutathionyl-cobalamin is 
predicted to be rapid and essentially irreversible under physiological conditions (82), and the 
very relevance of cyanocobalamin in biology is uncertain. Although cyanocobalamin is the 
cofactor form used in many vitamin supplements today, in the absence of a known biological 
source of this derivative, the question as to whether mammalian cells would have evolved a 
system to specifically catalyze its decyanation is an open one. Thus, while cblC is the most 
common of the inherited disorders in cobalamin utilization, the nature of its encoded function 
is presently unclear. 
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The cblD defect is enigmatic. Initially described in only two patients who were siblings, it 
was reported to result in a combined deficiency of methionine synthase and 
methylmalonyl-CoA mutase (83). As described above, limited biochemical characterization 
of these cell lines revealed similarities to cblC cells, albeit with deficits that were less severe 
(79). A more recent study on three additional patients revealed hetero-geneity within the 
cblD mutant class, which has consequently been divided into variants 1 and 2 respectively 
(72). Variant 1 is associated with an isolated deficiency in MeCbl synthesis and variant 2 
with an isolated defect in AdoCbl synthesis (Figure 1.12). On the basis of these observations, 
it has been suggested that a single cblD gene product “presents” B12 to methionine synthase 
and to the mitochondrial membrane or that alternative splicing results in cytosolic and 
mitochondrial variants of the resulting protein (72). Mutations in cblD affecting B12 binding 
would result in a combined deficiency of both cofactors whereas other mutations could 
impair interactions with one or the other protein target. 
 Inherited Defects Affecting Only MeCbl Synthesis. The defects in the cblE and cblG 
cell lines have been localized to methionine synthase reductase (84, 85) and methionine 
synthase (86, 87), respectively. Methionine synthase belongs to the subfamily of 
B12-dependent methyltransferases and the cofactor alternates between the MeCbl and 
cob(I)alamin oxidation states during the reaction cycle. Occasional oxidation of the reactive 
cob(I)alamin intermediate is the source of the inactive cob(II)alamin form of the enzyme, 
which is repaired via a reductive methylation reaction to MeCbl (88). The source of electrons 
for the reactivation reaction is NADPH, which is delivered via the dual flavoprotein 
oxidoreductase, methionine synthase reductase, to cob(II)alamin bound to methionine 
synthase (89). The activation reaction illustrates the sufficiency of the cblG and cblE loci for 
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converting cob(II)alamin to the active MeCbl cofactor form and precludes requirement for 
additional cytosolic reductases or factors for this reaction. 
 Inherited Defects Affecting Only AdoCbl Synthesis. The defect in the cblA cell line 
was postulated to be a mitochondrial cob(II)alalmin reductase (90, 91). However, the 
biochemical rationale for a stand-alone cob(II)alalmin reductase is weak, since its product, 
cob(I)alamin, is highly reactive and would rapidly succumb to side reactions. Furthermore, 
cob(II)alamin bound to the protein encoded by the cblB locus, adenosyltransferase, is 
reduced to cob(I)alamin in situ, in the first step of the reductive adenosylation reaction that 
generates AdoCbl (92). While the dual flavooprotein reductase, methionine synthase 
reductase, can serve as the reductase in vitro (93), the existence of a mitochondrial reductase 
dedicated for reduction of cob(II)alamin bound to adenosyltransferase appears unlikely based 
on the recent identification of all the mitochondrial specific cbl functions (93-95). Instead, a 
reductase that serves additional mitoochonndrial acceptors is likely used for the 
adenosylltransferase, explaining why it is not associated with a specific cbl defect. The recent 
identification of the genetic locus revealed a 418 residue long protein, designated MMAA 
(for causing methylmalonic aciduria type A) (95). It belongs to the G3E family of P-loop 
GTPases and contains the signature motifs associated with this superfamily. A bacterial 
ortholog of MMAA, MeaB, which is strongly conserved in operons encoding 
methylmalonyl-CoA mutase, is better characterized (96). MeaB exhibits low intrinsic 
GTPase activity that is activated >100-fold in complex with the mutase. MeaB in turn 
influences the mutase, protecting it from oxidative inactivation, but only in the presence of 
nucleotides. These results suggest that in addition to the mutase, MeaB interacts with 
adenosyltransferase and influences AdoCbl synthesis in mitochondria. 
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As expected from biochemical studies on cblB cell lines, the defect in them resides in the 
gene encoding adenosyltransferase also designated MMAB (for causing methylmalonic 
aciduria type B) (93, 94). Unlike methionine synthase that is the site for MeCbl synthesis in 
the presence of the auxiliary protein, methionine synthase reductase, inactive cofactor bound 
to methylmalonyl-CoA mutase cannot be converted to AdoCbl in situ. This activity is 
catalyzed by adenosyltransferase that converts cob(II)alamin or aquocobalamin in the 
presence of a reductant to AdoCbl. The human enzyme is trimeric and binds the various 
cobalamin derivatives with moderate affinity (~2–8 µM) (97). Spectroscopic analyses have 
revealed an unusual coordination environment for the cofactor bound to the enzyme, which is 
“base-off” in both the substrate cob(II)alamin and product AdoCbl oxidation states (97, 98). 
In the presence of ATP, four-coordinate cob(II)alamin with very unusual electron 
paramagnetic resonance and magnetic circular dichroism spectroscopic properties is observed 
(98). 
Thesis Organization 
 This dissertation consists of five chapters. Chapter 1 includes an introductory review 
about the history of vitamin B12 studies as well as the properties and functions of vitamin B12. 
Chapter 2 is a paper that was published in the journal Biochemistry. Chapter 3 is a paper that 
was published in the journal Journal of Biological Chemistry. Chapter 4 is a paper to be 
submitted to the journal Journal of Biological Chemistry. Chapter 5 is a general concluding 
chapter, where the results and conclusions of the three papers are summarized. All of the 
papers were written by me with the editorial guidance and assistance from my major 
professors, Dr. Thomas Bobik. 
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Figure 1.1 The structure of vitamin B12. The left figure is cited from Wikimedia Commons. 
The right figure is the stick model of cyanocobalamin, based on 3DChem.com model. 
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Figure 1.2 E°-pH diagram of Co(III)-Co(II)-Co(I) in water at 22 °C. Potentials are referred 
to the saturated calomel electrode (19). 
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Figure 1.3 Overview of B12 synthetic pathway (23). Parts I, II, and III are portions of the 
cobalamin biosynthetic pathway defined by nutritional behavior of mutants. The two 
pathways leading to Ado-Cbi are the aerobic pathway of P. denitrificans (top arrow) and the 
anaerobic pathway of S. typhimurium (bottom arrow). General functions of cofactors are 
indicated above and below the pathway. 
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Figure 1.4 Distribution of vitamin B12 synthesis. The lineages indicated in color have at 
least some members that synthesize B12. The above tree was made primarily form computer 
analysis of 16s (prokaryotes) and 18s (eukaryotes) ribosomal RNA sequences (Wheelis et.al). 
 41
 
 
Figure 1.5 Biosynthesis of precorrin 6 (aerobic pathway; light arrows) and cobalt–precorrin 
6 (anaerobic pathway; bold arrows) on the route from ALA to vitamin B12 (24). The two 
pathways are identical from ALA to precorrin 2, at which point they diverge as shown. PBG, 
porphobilinogen; HMB, hydroxymethylbilane; SAM, S-adenosyl-L-methionine. 
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Figure 1.6 Complete aerobic pathway from UroIII to adenosylcobalamin (24). Vitamin B12 
is formed by replacing the adenosyl group of the final product of this pathway, 
adenosylcobalamin, with cyanide. SAM, S-adenosyl-L-methionine; Ado-, adenosyl. 
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Figure 1.7 Regulation of the cob/pdu regulon of S. typhimurium (23). The genetic map 
describes the region between pdu and cob operons whose transcripts start at the far sides of 
the figure. Boxes enclose structural genes. Black arrows designate transcripts. Gray arrows 
indicate regulatory influence; dashed gray arrows indicate the proposal that a higher level of 
PocR protein may be required to activate these promoters. 
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Figure 1.8 Cobalamin-dependent pathways known for enteric bacteria (23). Only the first 
reaction for each pathway employs cobalamin as a cofactor. 
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Figure 1.9 The reactions catalyzed by methionine synthase (44). 
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Figure 1.10 Postulated reaction mechanism of methylmalonyl-CoA mutase. M-CoA and 
S-CoA denote methylmalonyl-CoA and succinyl-CoA, respectively (50). 
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Figure 1.11 Role of methylmalonyl-CoA mutase in animal and bacterial physiology (34). 
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Figure 1.12 Cobalamin metabolism in mammalian cells (33). The pathways by which 
vitamin B12 (cobalamin) is taken up by cells and converted to its active coenzyme derivatives 
are shown. The steps affected by inborn errors of cobalamin metabolism (cblA-cblH, mut), as 
well as MTHFR deficiency are shown. The methionine synthase reaction (cblG) is shown 
twice in order to separate folate and homocysteine metabolism. Abbreviations: AdoCbl, 
Adenosylcobalamin; AdoMet, S-adenosylmethionine; 5-Methyl-THF, methyltetrahydrofolate; 
MTHFR, methylenetetrahydrofolate reductase; TCII, transcobalamin II. 
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Figure 1.13 The gastrointestinal pathway for cobalamin absorption from dietary sources of 
cobalamin (73). Cbl: cobalamin; HC: haptocorrin (transcobalamin I/III); IF: intrinsic factor; 
TCII: transcobalamin II. 
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CHAPTER 2 FUNCTIONAL CHARACTERIZATION AND MUTATION 
ANALYSIS OF HUMAN ATP:COB(I)ALAMIN ADENOSYLTRANSFERASE 
A paper published in Biochemistry, 2008, 47(9), 2806-2813 
Chenguang Fan and Thomas A. Bobik 
Abstract 
ATP:cob(I)alamin adenosyltransferase catalyzes the final step in the conversion of 
vitamin B12 into the active coenzyme, adenosylcobalamin. Inherited defects in the gene for 
the human adenosyltransferase (hATR) result in methylmalonyl aciduria (MMA), a rare but 
life-threatening illness. In this study, we conducted a random mutagenesis of the hATR 
coding sequence. An ATR-deficient strain of Salmonella was used as a surrogate host to 
screen for mutations that impaired hATR activity in vivo. Fifty-seven missense mutations 
were isolated. These mapped to 30 positions of the hATR, 25 of which had not previously 
been shown to impair enzyme activity. Kinetic analysis and in vivo tests for enzyme activity 
were performed on the hATR variants, and mutations were mapped onto a hATR structural 
model. These studies functionally defined the hATR active site and tentatively implicated 
three amino acid residues in facilitating the reduction of cob(II)alamin to cob(I)alamin which 
is a prerequisite to adenosylation. 
Introduction 
In higher animals, two cobalamin (B12)-dependent enzymes are known. 
Methylcobalamin-dependent methionine synthase is needed for recycling homocysteine to 
methionine (1, 2), and adenosylcobalamin-dependent methylmalonyl-CoA mutase (MCM) is 
essential for the conversion of propionyl-CoA to the TCA cycle intermediate, succinyl-CoA 
 51
(3). In higher animals, propionyl-CoA is produced from the breakdown of branched-chain 
amino acids as well as thymine, cholesterol, and odd-chain fatty acids. Hence, MCM is 
essential for the complete catabolism of these compounds (3). 
Humans are incapable of synthesizing AdoCbl and MeCbl de novo and depend on 
assimilation of exogenous complex precursors such as vitamin B12 (cyanocobalamin, 
CN-Cbl) and hydroxycobalamin (OH-Cbl). For AdoCbl synthesis, CN-Cbl is converted to 
GS-Cbl, successively reduced to cob(II)alamin and cob(I)alamin, and finally adenosylated to 
AdoCbl (4-6). For MeCbl synthesis, cob(II)alamin is reductively methylated while bound to 
MS (2, 7, 8). In humans, inherited defects in the genes for MCM (mut), MS (MTR), or the 
genes for cobalamin metabolism lead to methylmalonyl aciduria (MMA), homocystinuria, or 
combined disease (9, 10). Patients typically present within the first year of life with lethargy, 
failure to thrive, recurrent vomiting, dehydration, respiratory distress, and hypotonia and are 
prone to life-threatening acidosis (11). 
The final step in the conversion of vitamin B12 to AdoCbl is catalyzed by 
ATP:cob(I)alamin adenosyltransferase (ATR) (5, 12). Three families of ATRs that are 
unrelated in amino acid sequence have been identified: CobA type, PduO type and EutT type 
(13-16). The human adenosyltransferase (hATR) is a PduO type enzyme (17). The gene for 
hATR is MMAB, and defects in this gene underlie the cblB complementation group of 
isolated MMA (18). The crystal structures of the hATR and two related bacterial enzymes 
from Lactobacillus reuteri and Thermoplasma acidophilum were recently determined 
(19-21). These enzymes are trimers, where the monomer is a five-helix bundle and the active 
site is at the subunit interface. The structures of the human and L. reuteri enzymes were 
determined with MgATP bound which identified a unique ATP-binding motif (19, 20). These 
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studies also showed that binding of MgATP increased the order of ~20 N-terminal amino 
acids, creating a novel MgATP binding site that is part of a larger cleft proposed to include 
the cobalamin binding site. Thus far, a structure of a PduO-type ATR with cobalamin bound 
has not been reported, although a structure for a CobA-type ATR with cobalamin bound is 
available (22). 
Recent spectroscopic studies indicate that in the presence of MgATP, hATR binds 
cob(II)alamin in a four-coordinate form in which dimethylbenzimidizole (DMB) is not 
coordinated to the cobalt in contrast to cob(II)alamin in solution at physiological pH where 
DMB is the lower axial ligand to cobalt (23). Dissociation of DMB changes the redox 
potential for the cob(II)alamin/cob(I)alamin couple from -610 mV to approximately -500 mV 
(24), and this increase in potential is proposed to facilitate cob(II)alamin reduction in vivo 
(25). In addition to preferentially binding cob(II)alamin in a DMB-off form, the hATR also 
binds AdoCbl DMB-off which may facilitate coenzyme transfer to MCM which binds 
cobalamin with H626 replacing DMB as the lower ligand to cobalt (25). 
Studies with the hATR and the CobA and PduO ATRs from Salmonella indicate that 
these enzymes closely interact with partner reductases and that cob(I)alamin is not produced 
free in solution but rather exists as an enzyme-bound species that is rapidly adenosylated to 
AdoCbl (26-28). It has been proposed that this is essential to prevent byreaction of 
cob(I)alamin which is one of the strongest nucleophiles known in biology (29). Mechanistic 
studies of the PduO enzyme of Salmonella indicate a ternary complex mechanism rather than 
a substituted enzyme mechanism (30). Cumulatively, the studies mentioned above lead to a 
general model for ATR function in which MgATP binds first followed by cob(II)alamin and 
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cobalamin reductase. Subsequently, cob(II)alamin is reduced to cob(I)alamin which is 
adenosylated to AdoCbl. 
To date, relatively little work has been reported that describes how amino acid changes 
affect the activity of PduO-type ATRs such as the human enzyme. The effects of four amino 
acid changes (R186W, R190H, R191W, and E193K) on hATR activity were determined, and 
three of the four corresponding amino acid residues were also studied in the Thermoplasma 
enzyme (21, 31). No general study on the effects of mutations on hATR activity and function 
has been reported. Therefore, we conducted a random mutagenesis of the hATR using 
Salmonella as a surrogate host to screen for changes in enzyme activity in vivo. 57 missense 
mutations at 30 positions were found to impair hATR activity in vivo in the surrogate host. 
These included mutations at 25 new sites that eliminate or reduce the hATR activity and 
hence could result in MMA if found in humans. In addition, we performed kinetic analysis 
and in vivo tests for enzyme activity on the hATR variants and mapped the mutations isolated 
onto a hATR structural model. These studies functionally defined the hATR active site and 
tentatively indicate a role for three amino acid residues in facilitating cob(II)alamin reduction 
by mediating the DMB-off transition. 
Materials and Methods 
Chemicals and Reagents. Dithiothreitol (DTT), OH-Cbl, and AdoCbl were purchased 
from Sigma (St. Louis, MO). Titanium(III) citrate was prepared as described previously (32). 
Isopropyl β-D-thiogalactopyranoside (IPTG) was from Diagnostic Chemical Ltd. 
(Charelottetown, PE). Restriction enzymes and T4 DNA ligase were from New England 
Biolabs (Beverly, MA). Pefabloc SC PLUS was purchased from ICN Biomedicals, Inc. 
(Aurora, OH). Other chemicals were from Fisher Scientific (Norcross, GA). 
 54
Bacterial Strains, Media and Growth Conditions. The bacterial strains used in this 
study are listed in Table 2.1. The minimal medium used was NCE supplemented with 0.4% 
1,2-propanediol (1,2-PD), 1 mM MgSO4, 200 ng/mL OH-B12, and 3 mM (each) valine, 
isoleucine, leucine, and threonine. LB (Luria-Bertani) medium was the rich medium used. 
MacConkey–1,2-PD–OH-Cbl indicator plates were composed of MacConkey agar base 
(Difco, Detroit, MI) supplemented with 1% 1,2-PD and 200 ng/mL OH-Cbl. 
General Molecular and Protein Methods. Bacterial transformation, PCR, restriction 
enzyme digests, and other standard molecular and protein methods were performed as 
described previously (13, 33). 
Cloning of hATR Coding Sequence for High Level Expression and 
Complementation of ATR-Deficient Salmonella. PCR was used to amplify hATR coding 
sequence. Primers were chosen that remove the predicted 36 amino acid N-terminal 
mitochondrial targeting sequence (MTS). Plasmid pNL166 provided the template DNA (17). 
The primers used for amplification were 5'-GCC GCC AGA TCT TAT GCC TCA GGG 
CGT GGA AGA CGG G-3' (forward) and 5'-GCC GCC AAG CTT ATC AGA GTC CCT 
CAG ACT CGG CCG-3' (reverse) for native hATR. Primer 5'-GCC GCC AGA TCT TAT 
GCA CCA TCA CCA TCA TCA CCA CCA TCC TCA GGG CGT GGA GAC GGG-3' was 
used to introduce an N-terminal His8 tag, and primer 5'-GCC GCC AAG CTT ATC AAT 
GGT GGT GAT GAT GGT GAT GGT GGA GTC CCT CAG ACT CGG CCG-3' was used 
to introduce a C-terminal His8 tag. These primers also introduced BglII and HindIII 
restriction sites into the PCR products which were used for cloning into pTA925 restricted 
with BglII and HindIII. Ligation mixtures were used to transform E. coli DH5α by 
electroporation, and transformants were selected on LB medium containing 25 ug/mL 
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kanamycin. Plasmid DNA was purified from these strains, and the DNA sequence of each 
clone was determined. Clones with the expected DNA sequence were restricted with SphI 
and XbaI and ligated with a linker having the sequence 5'-CAA TTA ATA CGA CTC ACT 
ATA GAC CCC AGG CTT GAC ACT TTA TGC TTC CGG CTC TAT AAT GTG TGG 
AAT TGT GAG CGG T-3' and 5'-CTA GAC CGC TCA CAA TTC CAC ACA TTA TAG 
AGC CGG AAG CAT AAA GTG TCA AGC CTG GGG TCT ATA GTG AGT CGT ATT 
AAT TGC ATG-3'. Ligation mixtures were used to transform E. coli DH5α by 
electroporation. Transformants were selected on LB medium with 25 ug/mL kanamycin. 
Plasmid DNA was purified from these strains, and the DNA sequence of the linker region 
was verified. The linker introduced both E. coli and T7 promoters which allowed high-level 
protein production in BL21DE3 RIL as well as complementation of the ATR-deficient 
Salmonella strain used for identification of hATR mutations. 
Growth of hATR Expression Strains and Preparation of Cell Extract. The E. coli 
strains used for expression of hATR were grown on 400 mL LB supplemented with 25 
ug/mL kanamycin at 16 °C in a New Brunswick Scientific Innova 4230 refrigerated shaker 
incubator with a shaking speed at 275 rpm. Cells were grown to an absorbance of 0.6–0.8 at 
600 nm, and protein expression was induced by the addition of 0.5 mM IPTG. Cells were 
incubated at 16 °C with shaking at 275 rpm for an additional 18 h. Cells were removed from 
the incubator, held on ice for 10 min, and then harvested by centrifugation at 8000 rpm for 5 
min using a Beckman JA-10 rotor. The cells were resuspended in 10 mL of 50 mM Tris and 
300 mM NaCl (pH 7.5), and broken using a French pressure cell (Thermo Electron Corp.) at 
10000 psi. Pefabloc SC PLUS was added to the cell extract to a concentration of 100 ug/mL 
to inhibit proteases. The crude cell extract was centrifuged at 16000 rpm for 30 min using a 
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Beckman JA-17 rotor to separate the soluble and insoluble fractions. The supernatant was the 
soluble fraction used for enzyme purification. 
Western Blots. The soluble fractions of cell extracts were fractionated by 12% 
SDS-PAGE and transferred onto a nitrocellulose membrane (Bio-Rad). The membrane was 
incubated at room temperature with gentle shacking in 50 mM Tris (pH 7.4), 200 mM NaCl, 
0.1% Tween (TTBS), and 5% Milk blocking buffer for 30 minutes. The primary antibody 
used was the affinity-purified rabbit IgG anti-hATR diluted 1:1000. The secondary antibody 
was the goat anti-rabbit IgG (H+L) alkaline phosphatase conjugate (Bio-Rad) at a 1:3000 
dilution. The membrane was prepared for detection using the alkaline phosphatase conjugate 
substrate kit (Bio-Rad). 
ATP:Cob(I)alamin Adenosyltransferase Assays. ATR assays were performed as 
previously reported with some modifications (30). Reaction mixtures contained 200 mM 
Tris-HCl (pH 8.0), 5 mM MgCl2, 10 mM KCl, 0.05 mM OH-Cbl, 0.5 mM ATP, and 1 mM 
titanium(III) citrate in a total volume of 2 mL. Reaction components (except for hATR) were 
dispensed into cuvettes inside an anaerobic chamber (Coy Laboratories, Grass Lake, MI). 
The cuvettes were sealed, removed from the chamber, and incubated at 37 °C for 5 min. 
Reactions were initiated by addition of purified recombinant hATR, and AdoCbl formation 
was measured by following the decrease in absorbance at 388 nm (ε388 = 24.9 cm-1 mM-1). 
Random Mutagenesis and Screening of Candidate Human ATR Mutants. Random 
mutagenesis of the hATR gene was carried out using the E. coli mutator strain XL1-Red 
(Stratagene). pCF13 (His8-hATR) and pCF15 (hATR-His8) were transformed into XL1-Red 
by chemical transformation selecting for kanamycin resistance on LB medium. 
Approximately 3000 transformants were pooled and subcultured 5-10 times in 100 mL of LB 
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medium inoculated with 0.5 mL of an LB culture. pCF13 and pCF15 DNA was purified and 
used to transform the ATR-deficient bacterial mutant BE620 via electroporation. 
Transformants were screened on MacConkey-1,2-PD–OH-Cbl indicator plates supplemented 
with kanamycin at 25 µg/mL. 
Growth Tests. AdoCbl-dependent growth on 1,2-PD minimal medium was performed as 
previously described in 48-well microtiter plates (13, 17). 
UV-Visible Spectroscopy for Examination of the Lower Axial Ligand of AdoCbl. 
Spectra were obtained using a Cary 50 Bio spectrophotometer (Varian). 1 mL soluble cell 
extract containing 10 mg of protein was added to 1 mL plastic cuvette, and the mixture was 
scanned from 300 to 600 nm as the baseline. Then, 2 µL of 5 mM AdoCbl (finally 5 µM) was 
added to the sample and gently mixed. After incubation at 37 °C for 2 minutes, the cuvette 
was scanned a second time from 300 to 600 nm. 
EPR Spectroscopy for Examination of the Lower Axial Ligand of Cob(II)alamin. 
Spectra were obtained using Bruker ER-200 EPR system. Cob(II)alamin was generated by 
photolysis of AdoCbl under anaerobic conditions in 10 mM Tris-HCl (pH 8.0). Purified 
hATR (2 mM) was incubated with 2 mM ATP anaerobically for 20 min at 4 °C. Then, 
cob(II)alamin was added to a final concentration of 100 µM. The mixture was equilibrated 
for 5 min at 37 °C and then injected into 4mm quartz EPR tubes. 
DNA Sequencing. DNA sequencing was carried out by Iowa State University, at the DNA 
facility of the Iowa State University Office of Biotechnology. 
Results 
An in vivo Screen for hATR Mutants. Wild-type Salmonella produces red colonies on 
MacConkey-1,2-PD-B12 indicator media as a result of AdoCbl-dependent 1,2-PD degradation 
 58
(34). Salmonella strain BE620 produces white colonies on similar media due to ATR 
deficiency (13). The phenotype of BE620 was complemented by pCF13 (His8-hATR) or 
pCF15 (hATR-His8), but not by a plasmid without an insert. Hence, pCF13 or pCF15 with a 
hATR inactivated by mutation was expected to produce white or pink colonies in BE620 
rather than wild-type red, providing a convenient in vivo screen for hATR mutants.  
E. coli mutator strain XL1-Red was used for random mutagenesis of pCF13 (His8-hATR) 
and pCF15 (hATR-His8). Mutagenized plasmid DNA was transformed into the 
ATR-deficient bacterial mutant Salmonella BE620, and resultant colonies were screened for 
color formation on MacConkey-1,2-PD-B12 indicator media. Approximately 6000 
transformants were screened, 3000 derived from each mutagenized plasmid. Of these, 185 
produced colonies that were white or pink in color, suggesting that they carried a mutant 
hATR coding sequence. These included 57 single-base change missense mutations at 30 
positions of the hATR gene with K78 and G97 each having two different mutations. 
Effect of B12 Concentration on the Activity of hATR Variants in vivo. We also used 
indicator plates with different amounts of OH-Cbl to view the sensitivity of the mutants to 
B12 concentration. Eleven mutants, G63E, D64G, R76G, K78R, G97R, G97E, S126L, 
H183Y, R215K, D218N, and R225K, had an increased level of color formation (ATR 
activity) at 1500 nM compared to 150 nM OH-Cbl. Of these amino acid residues, G63 and 
K78 directly contact MgATP in the structural model, and residues D64, R76, S126, R215, 
D218, and R225 are at the surface of the proposed active site pocket in position to interact with 
MgATP or cobalamin. Thus, these results indicate that residues G63, D64, R76, K78, S126, 
R215, D218, and R225 are important to binding of MgATP/cobalamin by the hATR in vivo. 
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Results also showed that most of the mutants that were partly corrected by the increased 
B12 concentration had an elevated Km for MgATP, cobalamin, or both substrates. This finding 
is consistent with the proposal that MgATP and cobalamin binding are interrelated which was 
indicated by structural studies that showed MgATP binding leads to ordering of the N-terminal 
portion of the hATR with formation of a proposed cobalamin-binding site (19). 
We also found that two hATR mutations that are partly corrected by increased B12 levels in 
vivo (R215K and R225K) lack measurable activity in vitro, and two other B12-sensitive 
mutations (G97R and H183Y) are at the inner part of the protein distant from the active site. 
Apparently, the R215K and R225K mutants are stabilized somewhat by the in vivo milieu, and 
G97R and H183Y affect the shape of the active site at a distance. 
In vivo Stability of hATR Mutants. The stability of the mutant hATR proteins in 
Salmonella BE620 was examined by Western blotting (Figure 2.1). Each lane contains 10 µg 
of protein. From these gels, it can be seen that most of the mutant hATRs were expressed at a 
level within ~2-fold of the control. However, mutant proteins C119Y, R186W, C189Y, 
R190C, and R191W were produced at much lower levels than the control, indicating that 
these mutations impair proper protein folding leading to degradation by cellular proteases. 
Most of the unstable mutants are located in a highly conserved region of the hATR, and three 
of five have been found in MMA patients (18). 
B12-Dependent Growth of hATR Mutants in a Surrogate Host. Ectopic expression of 
His8-hATR, hATR-His8, or native hATR in ATR-deficient Salmonella restored 
AdoCbl-dependent growth on 1,2-PD which was previously shown with native hATR (13) 
(Figure 2.2). Although the growth rate obtained via ectopic expression of His8-ATR was 
approximately half of that with native hATR or hATR-His8, it was still much higher than the 
 60
control; hence, we were able to further evaluate the in vivo activity of all hATR mutants with 
growth studies. With one exception (T161I), none of the hATR missense mutants enhanced 
the growth of ATR-deficient Salmonella BE620 on 1,2-PD. The T161I mutant was capable 
of slow growth
. 
These results indicate that the 32 hATR missense mutants isolated here had 
little to no ATR activity in vivo when Salmonella was used a surrogate host. 
Kinetic Values for Human ATR Mutants. Using purified enzymes (Figure 2.3), kinetic 
constants were determined for the wild-type and mutant hATRs. Km and kcat values were 
determined by nonlinear regression with Grafit (Table 2.2). When the Km values for ATP 
were determined, saturating levels of cob(I)alamin (50 µM) were added to assay mixtures 
and the ATP concentration was varied from 0 to 200 µM. Similarly, saturating levels of ATP 
(500 µM) and varying levels of cob(I)alamin from 0 to 50 µM were used to determine the Km 
values for cob(I)alamin. 
Controls showed that hATR-His8 and native hATR had similar activity. The N-terminal 
His8 tag enzyme had a lower kcat value (58%), showing that the N-terminal tag affected 
enzyme activity somewhat. Kinetic analysis of the hATR missense mutants indicated four 
distinct groups. 
Group I consisted of 19 mutants (K78Q, E84K, G87R, D90N, E91K, L92S, S94L, 
R186W, C189Y, R190C, R191W, E193K, R194G, F212S, R215K, S217R, L220P, L223P, 
and R225K) that had no activity even with a 10-fold excess of ATP and cob(I)alamin 
compared to the standard assay (13). Most of these had mutations that changed conserved 
amino acid residues (17). Among these, R186W, R190C, R191W, and E193K have been 
found in methylmalonic aciduria patients (18). Note that although R186W, C189Y, R190C, 
and R191W were unstable when expressed in ATR-deficient Salmonella BE620 at moderate 
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levels (Figure 2.1), it was still possible to purify these proteins following high-level 
expression in E. coli BL21DE3 RIL. 
Group II consisted of three mutants that exhibited relatively large changes in the Km 
values for both ATP and cob(I)alamin: R76G, F83S, and S126L. Their Km values for ATP 
were 45.89 ± 8.17 µM, 215 ± 37 µM, and 87.70 ± 40.98 µM, respectively, while the 
wild-type was 6.90 ± 0.36 µM. Km values for cob(I)alamin were 9.09 ± 1.89 µM, 30.2 
± 12.5 µM, and 14.25 ± 4.49 µM, respectively, while the wild-type was 1.60 ± 0.55 
µM. Residue F83 has direct contact with MgATP in the crystal structure, and R76 and S126 
map to the surface of the active site pocket. Hence, these residues are likely critical for 
proper binding of MgATP and/or cobalamin. 
Group III mutants (G63E, D64G, S68F, K78R, G97R, and D218N) showed modest 
changes or wild-type Km values for ATP and cob(I)alamin, but a substantially reduced Vmax. 
Three of these residues interact directly with MgATP (G63, S68, and K78), and the 
remainder of the residues (D64, G97, and D218) map to the surface of the proposed active 
site pocket. Hence, these amino acid residues likely define the enzyme active site. 
Group IV mutants (G97E, C119Y, T161I, and H183Y) had kinetic constants in the 
wild-type range. This raises the question of why these mutants were inactive in Salmonella in 
vivo. Western blots showed that hATR-C119Y was produced only at a low level in vivo 
(Figure 2.1); hence, it may have been inactive in vivo due to instability. However, the G97E, 
T161I, and H183Y hATR variants were all produced at near wild-type levels in vivo. We 
speculate that these mutations interfere with the reduction of cob(II)alamin to cob(I)alamin in 
vivo and thereby impair hATR activity. For the in vitro assay, cob(I)alamin is provided by 
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use of a strong chemical reductant Ti(III); hence, a defect that impairs the reduction of 
cob(II)alamin to cob(I)alamin would not be detected by this test. 
Effect of Mutations on AdoCbl Binding. Prior studies showed that binding of AdoCbl 
to native hATR results in a large blue shift in its UV-visible spectrum from 540 to 460 nm 
because AdoCbl is bound base-off (without DMB as the lower axial ligand to cobalt) (25). It 
was proposed that this mode of binding allows efficient transfer of AdoCbl to MCM which 
binds AdoCbl in the base-off mode with H626 replacing DMB as the lower axial ligand of 
cobalt (25). Therefore, we examined the effects of hATR missense mutants on the DMB-off 
transition. Controls showed that binding of AdoCbl to native hATR and hATR-His8 resulted 
in the anticipated blue shift in the UV-Visible spectrum (Figure 2.4A). Unexpectedly, 
however, binding of AdoCbl to His8-hATR resulted in no obvious changes in the UV-Visible 
spectrum (Figure 2.4B). This indicated that the N-terminal His8 tag interfered with the ability 
of the hATR to mediate the base-off transition of AdoCbl. Consequently, further studies of 
this transition focused on variants of the hATR with the C-terminal His8 tag. 
Among the hATR missense mutants with C-terminal His8 tag (S68F, K78Q, K78R, 
R186W, and R190C) mediated blue shifts similar to that of the wild-type hATR. However, 
the majority of the hATR missense mutants, including D64G, F83S, G87R, D90N, E91K, 
L92S, S94L, C189Y, R191W, E193K, R194G, F212S, S217R, L220P, and L223P, lacked a 
measurable blue shift. The fact that most of the hATR mutants were unable to mediate the 
base-off transition of AdoCbl suggests that this conversion is a key aspect of the enzyme 
mechanism and that most of these mutations affect cobalamin binding. 
Effect of Mutations on Cob(II)alamin Binding. Previous studies showed that in the 
presence of ATP, hATR binds cob(II)alamin in the base-off form (23, 25). Base-off binding 
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is proposed to raise the Co2+/1+ reduction potential from -610 to -500mV, thus activating the 
cob(II)alamin for reduction (24). Prior studies distinguished base-on and base-off 
cob(II)alamin by EPR spectroscopy (23). Base-on cob(II)alamin exhibits an EPR spectrum in 
which the octet of hyperfine lines is split into triplets (Figure 2.5A). In contrast, base-off 
cob(II)alamin has high-field lines that appear as singlets (Figure 2.5B). We examined 
cob(II)alamin binding by hATR and variants using EPR spectroscopy. Controls showed that 
His8-hATR bound cob(II)alamin base-on (Figure 2.5C) and that hATR-His8 bound 
cob(II)alamin base-off (Figure 2.5D). This indicated that the N-terminal His8 tag interfered 
with the ability of the hATR to mediate the base-off transition of cob(II)alamin which was 
also seen in the case of AdoCbl binding (see above). Among the hATR missense mutants 
with the C-terminal His8 tag, only S68F, K78Q, K78R, R186W, and R190C exhibited EPR 
spectra indicating base-off binding of cob(II)alamin. This result was consistent with that of 
AdoCbl base-off transition experiments described above, suggesting that base-off binding of 
AdoCbl and cob(II)alamin is mechanistically related. 
Discussion 
In this study, the hATR was subjected to random mutagenesis and an ATR-deficient 
Salmonella strain was used as a surrogate host to facilitate isolation and characterization of 
mutations that impaired hATR activity. This approach allowed isolation of a number of 
single-base change mutations that impaired hATR activity. Single-base changes are much 
more likely to arise in natural populations compared to two or three simultaneous base 
changes which are often used in site-directed mutagenesis studies. Thus, the mutations 
studied here are more likely to have relevance to MMA than multibase changes created by 
site-directed mutagenesis. In total, 57 missense mutations were found at 30 different sites of 
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the hATR, five of which were previously shown to be altered in MMA patients and 25 of 
which were at new sites. 
In addition to identifying mutations that have potential relevance to MMA, the studies 
reported here also help to functionally define the hATR active site. Analysis of hATR 
variants indicated that two small regions are particularly important for enzyme activity, 
E84-S94 and R186-R194. In the E84-S94 region, mutations in seven of 12 positions 
abolished enzyme activity, while in the R186-R194 region changes in six of nine residues 
eliminated activity. This suggests that these two short conserved regions are part of the hATR 
active site which is consistent with the crystal structure determined by Schubert and Hill (19). 
To realize a more detailed understanding of how the mutations isolated here affected 
hATR activity, we mapped them onto a hATR structural model with MgATP bound. The 
crystal shows that MgATP binding involves the formation of numerous hydrogen bonds and 
van der Waals interactions. ATP binding also increased the order of ~20 N-terminal amino 
acids, creating a novel ATP-binding site that was part of a larger cleft proposed to include the 
cobalamin binding site (19). Thirteen missense mutations isolated in this study affected 
residues directly involved in MgATP binding (G63E, D64G, S68F, K78R, K78Q, F83S, 
G87R, R190C, E193K, R194G, R215K, S217R, and D218N) (Figure 2.6A), and two 
missense mutations changed residues proposed to be involved in cobalamin binding (D90N 
and R186W). Hence, these mutations functionally define the hATR active site. 
We also examined hATR mutations that resulted in an abnormal Km value for 
cob(I)alamin or sensitivity to hydroxylcobalamin concentration in vivo. In addition to 
residues D90, F170, R186, and F221 which were previously suggested to aid cobalamin 
binding (19), we found that S94 sits at the inner surface of the proposed cobalamin binding 
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site and that mutation S94L resulted in an enzyme that was inactive in vitro and in vivo, 
suggesting a role for S94 in cobalamin binding not apparent in the crystal structure (Figure 
2.6B). 
The crystal structure of the hATR indicates a trimer structure is required for enzyme 
activity since the active site is at the monomer interfaces. The trimer interface contains two 
charged rings (E84/R195 and E91/R191) and two phenylalanine rings that form a solid core 
(19). Among these positions, three missense mutants were obtained (E84K, E91K, and 
R191W). Each lacked detectable hATR activity in vivo and in vitro, indicating that these 
positions are likely important for trimer formation. We did not obtain mutations that alter the 
phenylalanine residues at the core of the trimer. However, mutant L92S (Figure 2.6C), which 
is located at the trimer interface, also lacked measurable activity in vitro and in vivo. L92 
may make contact with V188 at the interface of the neighbor subunit. In addition, two 
mutants were obtained (L220P and L223P) that are expected to produce kinks in helix α5 
which is involved in active site formation. These two mutants also lacked measurable activity 
in vitro and in vivo. 
Recent spectroscopic studies indicate that the hATR binds cobalamin as a four-coordinate 
species in which DMB is no longer bonded to the central cobalt atom (23). This mode of 
binding (DMB-off) is proposed to raise the Co2+/1+ midpoint potential 110 mV (from -610 to 
-500 mV) bringing it into the physiological range (24). We found three hATR variants that 
had near normal activity in vitro but were stable and inactive in vivo (G97E, T161I, and 
H183Y). We speculate that these mutant enzymes might be unable to mediate the DMB-off 
transition in vivo and hence be inactive since formation of cob(I)alamin is a prerequisite for 
adenosylation. Such mutants would be expected to be inactive in vivo but active in vitro 
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because cob(I)alamin is provided through use of a strong chemical reductant. Alternatively, 
mutations G97E, T161I, and H183Y might impair interaction of the hATR with a partner 
reductase. Studies in several systems indicate that ATRs directly interact with cognate 
reductases to protect the highly reactive cob(I)alamin intermediate from side reactions 
(26-28). Impairment of this interaction would be expected to produce ATR that is active in 
vitro but not in vivo which was found for variants G97E, T161I, and H183Y. However, G97, 
T161, and H183 map to the interior of the hATR (Figure 2.6D); hence, it seems unlikely they 
would be able to interact with a partner protein. Therefore, we favor a possible role for G97, 
T161, and H183 in stabilizing four-coordinate cob(II)alamin. Each of these residues maps 
near a hydrophobic loop between α3 and α4 which we tentatively suggested is involved in 
DMB binding or otherwise facilitating cob(II)alamin reduction. 
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Table 2.1 Bacterial Strains Used in This Study 
 
 strain                    genotype 
Escherichia coli 
DH5α...................F- λ- endA1 hsdR17 relA1 supE44 thi-1 recA1 gyrA96 relA1 
∆(lacZYA-argF)U169 (φ80dlacZ∆M15) 
BL21DE3 RIL.....F- ompT hsdS (rB- mB-) dcm+ Tetr gal λ(DE3) endA Hte [argU ileY leuW 
Camr] 
XL-1 Red………endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac mutD5 mutS mutt Tn10 (tetr)a 
(bought from Stratagene) 
BE119..................BL21DE3 RIL/pTA925 (T7 expression vector without insert) 
BE260…………..DH5α/pNL166 (pLac22- hATR) 
BE702…………..BL21DE3 RIL/pCF13 (His8-hATR) 
BE704…………..BL21DE3 RIL/pCF15 (hATR-His8) 
BE706…………..BL21DE3 RIL/pCF19 (native hATR) 
 
Salmonella enterica serovar Typhimurium LT2 
BE121..................∆pduO651 cobA366::Tn10dCam 
BE620…………..∆pduO651cobA366::dCam ∆1955 (zfa3646*Tn10*zfa3648) 
BE701…………..BE620/pCF13 (His8-hATR) 
BE703…………..BE620/pCF15 (hATR-His8) 
BE705…………..BE620/pCF19 (native hATR) 
BE707…………..BE620/pCF (modified pTA925) 
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Table 2.2 Kinetics Constants for hATR Variants a 
 KmATP (µM) Kmcob(I) (µM) kcat (min-1) kcat /KmATP 
(µM-1 min-1) 
kcat /Kmcob(I) 
(µM-1 min-1) 
His8-hATR 7.19±0.10 1.58±0.65 2.77±0.27 0.39 1.75 
hATR-His8 7.35±0.67 1.60±0.44 4.96±0.26 0.67 3.10 
native hATR 6.90±0.36 1.60±0.55 4.75±0.23 0.69 2.97 
G63E 12.4±1.2 2.24±0.60 0.49±0.03 0.039 0.22 
D64G 20.5±2.8 1.94±0.64 0.53±0.04 0.026 0.27 
S68F 17.2±2.8 1.86±0.55 0.78±0.05 0.045 0.42 
R76G 45.9±8.2 9.09±1.89 2.58±1.20 0.056 0.28 
K78R 8.26±0.68 2.25±0.35 0.32±0.05 0.039 0.14 
F83S 215±37 30.2±12.5 2.07±1.58 0.010 0.07 
G97R 20.3±8.4 3.03±0.62 0.80±0.06 0.039 0.26 
G97E 5.23±1.25 2.52±0.79 2.38±0.13 0.46 0.94 
C119Y 14.1±1.7 5.13±1.82 4.06±0.30 0.29 0.79 
S126L 87.7±41 14.3±4.5 0.58±0.08 0.007 0.04 
T161I 5.00±0.91 2.71±0.25 2.29±0.05 0.46 0.85 
H183Y 9.97±2.01 7.13±1.06 2.83±0.43 0.28 0.40 
D218N 2.87±0.40 1.72±0.43 0.73±0.02 0.25 0.42 
a: The values shown are based on three replicates. Average values were used to calculate 
kcat/Km. Mutants without measurable ability are not shown in this table. Km and kcat values 
were determined by nonlinear regression with Grafit®. 
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Figure 2.1 Western blotting analysis of hATR mutants. All lanes were loaded with 10 µg 
of soluble cell extract. The following strains were used: strain BE707 (no insert control), 
strain BE701 (His8-hATR), strain BE703 (hATR-His8), and strain BE705 (native hATR). 
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Figure 2.2 Growth tests with hATR mutants using Salmonella as a surrogate host. The 
following strains were used: BE701 (His8-hATR), BE703 (hATR-His8), BE705 (native 
hATR), and BE707 (no insert control). The mutants were grown on minimal medium with 
1,2-PD as the only carbon source at 37 °C with shaking for 40 h. Cell growth was assessed 
by measuring OD600. The control strain containing plasmid without insert (BE707) was 
unable to grow on 1,2-PD-B12 minimal medium due to a lack of ATR activity. 
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Figure 2.3 SDS-PAGE analysis of hATR-His8 purification: Lane 1, molecular mass 
marker; lane 2, 10 µg of soluble extract of strain BE704 (hATR-His8); lane 3, 10 µg of 
flow-through fraction; lane 4, 5 µg of 80 mM imidazole wash fraction; and lane 5, 5 µg of 
250 mM imidazole elution fraction. The molecular mass of hATR-His8 is about 25 kDa. The 
gel contained 12% acrylamide. 
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Figure 2.4 Binding of AdoCbl by hATR. UV-visible spectra of (A) AdoCbl in the base-on 
and base-off conformations and (B) AdoCbl bound to recombinant hATRs. 1 mL soluble cell 
extract containing 10 mg of protein was scanned as the baseline. Then, AdoCbl was added to 
the sample and gently mixed. After incubation at 37 °C for 2 min, the cuvette was scanned a 
second time (shown). The strains used for hATR production were BE702 (His8-hATR), 
BE704 (hATR-His8), BE706 (native hATR), and BE119 (no insert control). 
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Figure 2.5 X-Band EPR spectra of (A) base-on cob(II)alamin [1mM cob(II)alamin in 10 
mM Tris-HCl buffer (pH 8.0)], (B) base-off cob(II)alamin [1mM cob(II)alamin in 1% 
H3PO4], (C) 100 µM cob(II)alamin in the presence of 2 mM purified His8-hATR and 2 mM 
ATP, and (D) 100 µM cob(II)alamin in the presence of 2 mM purified hATR-His8 and 2 mM 
ATP. Spectra were collected at 100K with a modulation amplitude of 4G, a modulation 
frequency of 100 KHz, a time constant of 100 ms and a microwave power of 20 mW. 
A 
1 x 
B 
2 x 
C 
5 x 
D 
10 x 
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Figure 2.6 Mapping of mutations on the hATR structural model. (A) Side view of 
mutations involved in MgATP binding. (B) Side view of mutations at the surface of the 
proposed cobalamin binding site. (C) Top view of mutations at the interface of the hATR 
trimer. (D) Side view of mutations proposed to facilitate the base-off transition. This figure 
was made using Yasara®. 
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CHAPTER 3 THE PDUX ENZYME OF SALMONELLA ENTERICA IS AN 
L-THREONINE KINASE USED FOR COENZYME B12 SYNTHESIS 
A paper published in Journal of Biological Chemistry, 2008, 283(17), 11322-11329 
Chenguang Fan and Thomas A. Bobik 
Abstract 
Here, the PduX enzyme of Salmonella enterica is shown to be an L-threonine kinase used 
for the de novo synthesis of coenzyme B12 and the assimilation of cobyric acid (Cby). PduX 
with a C-terminal His tag (PduX-His6) was produced at high levels in Escherichia coli, 
purified by nickel-affinity chromatography and partially characterized. 31P NMR 
spectroscopy established that purified PduX-His6 catalyzed the conversion of L-threonine 
and ATP to L-threonine-O-3-phosphate and ADP. Enzyme assays showed that ATP was the 
preferred substrate compared with GTP, CTP or UTP. PduX displayed Michaelis-Menten 
kinetics with respect to both ATP and L-threonine and nonlinear regression was used to 
determine the following kinetic constants: Vmax = 62.1 ± 3.6 nmol min-1 mg protein-1; KmATP 
= 54.7 ± 5.7 µM and KmThr = 146.1 ± 8.4 µM. Growth studies showed that pduX mutants 
were impaired for the synthesis of coenzyme B12 de novo and from Cby, but not from 
cobinamide which was the expected phenotype for an L-threonine kinase mutant. The defect 
in Cby assimilation was corrected by ectopic expression of pduX or by supplementation of 
growth medium with L-threonine-O-3-phosphate, providing further support that PduX is an 
L-threonine kinase. In addition, a bioassay showed that a pduX mutant was impaired for the 
de novo synthesis of coenzyme B12 as expected. Collectively, the genetic and biochemical 
studies presented here show that PduX is an L-threonine kinase used for AdoCbl synthesis. 
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To our knowledge, PduX is the first enzyme shown to phosphorylate free L-threonine and 
first L-threonine kinase shown to function in coenzyme B12 synthesis. 
Introduction 
The B12 coenzymes (adenosylcobalamin, AdoCbl, and methylcobalamin, MeCbl) are 
required cofactors for at least 15 different enzymes that are widely distributed in nature and 
are essential for human health (1, 2). AdoCbl and MeCbl are synthesized de novo by certain 
prokaryotes and from corrinoid precursors by a broader range of organisms (1, 2). The 
synthesis of B12 has been studied extensively in Salmonella enterica (3, 4). This organism 
carries out de novo synthesis under anaerobic conditions and assimilates corrinoids such as 
vitamin B12, cobinamide (Cbi) and cobyric acid (Cby) under both aerobic and anaerobic 
conditions (3, 5). Corrinoid assimilation begins with transport into the cytoplasm by the B12 
uptake system (btu) followed by synthetic steps specific to a particular corrinoid (Figure 3.1) 
(6-8). In the case of Cbi, an adenosyl-group is added to the central cobalt atom to form 
Adenosyl-Cbi which is phosphorylated to Adenosyl-Cbi-phosphate (9, 10). Subsequently, the 
nucleotide loop is assembled in three steps to form AdoCbl (3). Lastly, a portion of the 
AdoCbl is converted to MeCbl (11, 12).  
Many of the steps used for Cbi assimilation are also used for the assimilation of Cby as 
well as the de novo synthesis of AdoCbl and MeCbl (Figure 3.1). A key difference is that 
Cby assimilation and de novo synthesis require (R)-1-amino-2-propanol-O-2-phosphate 
(AP-P) whereas the conversion of Cbi to the B12 coenzymes does not (3) (Figure 3.1). Prior 
studies showed that AP-P was produced by decarboxylation of L-threonine-O-3-phosphate 
(L-Thr-P) which was catalyzed by the CobD enzyme (13). These findings predicted that an 
L-threonine (L-Thr) kinase would be required for the de novo synthesis of AdoCbl and 
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MeCbl, and the assimilation of Cby. However, this enzyme has not been identified in any 
system. 
In S. enterica, AdoCbl and MeCbl are required cofactors for three enzymes (5). 
MeCbl-dependent methionine synthase (MetH) is used to convert homocysteine to 
methionine (14); AdoCbl-dependent diol dehydratase and ethanolamine ammonia lyase are 
required for growth on 1,2-propanediol (1,2-PD) and ethanolamine, respectively (15, 16). 
The genes specific for 1,2-PD utilization (pdu) are found in a large contiguous cluster (15, 
17). Bioinformatic studies tentatively suggest that the last gene of the pdu operon (pduX) 
encodes an L-Thr kinase (18). The PduX protein has homology to GHMP (galactokinase, 
homoserine kinase, mevalonate kinase, and phosphomevalonate kinase) family of kinases and 
a number of PduX homologues are encoded by genes located proximal to genes for AdoCbl 
biosynthesis. However, no experimental studies of PduX homologues have been conducted in 
any system. 
Here, we present genetic and biochemical studies that show PduX is an L-Thr kinase used 
for the de novo synthesis of AdoCbl and the assimilation of Cby. To our knowledge, PduX is 
the first enzyme shown to phosphorylate free L-Thr. 
Experimental Procedures 
Chemicals and Reagents. Antibiotics, Cbi, L-Thr-P, (R)-1-Amino-2-propanol (AP), 
nucleoside triphosphates and nucleoside diphosphates were purchased from Sigma-Aldrich 
(St. Louis, MO). Isopropyl-β-D-thiogalactopyranoside (IPTG) was from Diagnostic 
Chemical Ltd., Charelottetown, Prince Edward Island, Canada. Restriction enzymes and T4 
DNA ligase were from New England Biolabs, Beverly, MA. Pefabloc SC PLUS was 
purchased from ICN Biomedicals, Inc. Aurora, OH. Other chemicals were from Fisher 
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Scientific, Norcross, GA. Cby was kindly provided by Kathy Krasny from the laboratory of 
J. Escalante-Semerena. 
Bacterial Strains, Media and Growth Conditions. The bacterial strains used in this 
study are listed in Table 3.1. The minimal medium used was NCE supplemented with 0.4% 
1,2-PD, 1 mM MgSO4, 50 µM Ferric citrate, 1 µM 5,6-dimethylbenzimidazole (DMB) and 3 
mM (each) valine, isoleucine, leucine, and threonine. LB (Luria-Bertani) medium was the 
rich medium used. 
General Molecular Methods. Agarose gel electrophoresis was performed as described 
previously (19). Plasmid DNA was purified by QIAGEN (Chatsworth, CA) products 
according to the manufacturer’s instructions. Following restriction digestion and PCR 
amplification, DNA was purified by Promega Wizard PCR Preps (Madison, WI). Restriction 
digests were carried out using standard protocols (19). For ligation of DNA fragments, T4 
DNA ligase was used according to the manufacturer’s instructions. Electroporation was 
carried out as previously described (17). 
Protein Methods. Polyacrylamide gel electrophoresis (PAGE) was performed by using 
Bio-Rad Ready gels and Bio-Rad Mini-Protean II electrophoresis cells according to the 
manufacturer’s instructions. Following gel electrophoresis, Coomassie Brilliant Blue R-250 
was used to stain proteins. The protein concentration of solutions was determined by using 
Bio-Rad protein assay reagent. 
Construction of Plasmids for Production of PduX and PduX-His6. PCR was used to 
amplify the pduX coding sequence from pEM55 (17). The primers used for amplification 
were 5’-GCC GCC AGA TCT ATG CGC GCA CAC TAT TCG TAC CT-3’ and 5’-GCC 
GCC AAG CTT ATC ACT GCA GTT TGA CCC CGC CA-3’. The reverse primer used for 
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fusing six histidine residues to the C-terminus of PduX was 5’-GCC GCC AAG CTT ATC 
AAT GAT GAT GAT GAT GAT GCT GCA GTT TGA CCC CGC CA-3’. These PCR 
primers introduced BglII and HindIII restriction sites that were used for cloning into vector 
pTA925 or pLac22 (20). Following ligation, clones were introduced into Escherichia coli 
DH5α by electroporation, and transformants were selected by plating on LB agar 
supplemented with 25 µg ml-1 kanamycin (pTA925) or 100 µg ml-1 ampicillin (pLac22). Pure 
cultures were prepared from selected transformants. The presence of insert DNA was verified 
by restriction analysis or PCR, and the DNA sequence of selected pduX clones was 
determined. Clones with the expected DNA sequence were used for further study. 
DNA Sequencing. DNA sequencing was carried out by Iowa State University, DNA 
facility of Iowa State University Office of Biotechnology using automated sequencing 
equipment from Applied Biosystems Inc. 
Growth Curves. Growth media are described in the figure legends. To prepare the 
inoculum, 2 ml LB cultures were incubated overnight at 37°C, and then cells were collected 
by centrifugation and suspended in growth curve medium. Media were inoculated to a 
density of 0.15 absorbance units, and the cell growth was monitored by measuring the optical 
density at 600 nm using a BioTek Synergy microplate reader and 48-well flat-bottom plates 
(Falcon). Each well was inoculated with 0.3 ml of culture and incubated at 37°C as described 
(21). 
Corrinoid Extraction and Quantification. Selected strains of S. enterica were grown 
aerobically on 5 ml LB medium supplemented with 1% 1,2-PD, 1 µM DMB and 5 µM CoCl2 
overnight at 37°C in 17 × 100 mm test tubes. Cells were collected by centrifugation and 
suspended in 1 ml, 50 mM Tris pH 7.0. The cell suspension was transferred into 3 ml serum 
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vials. The vials were sealed and flushed with helium for 3 minutes. The suspension was 
autoclaved for 10 minutes at 121°C, then placed on ice for 10 minutes and centrifuged at 
25,000 × g for 1 hour at 4°C. The corrinoids present in the supernatant were quantified using 
a bioassay based on the AdoCbl-dependent growth of S. enterica strain BE86 on the 
ethanolamine minimal medium. Growth measurements were carried out using a microplate 
reader as described above for “growth curves”. Quantitation was based on a standard curve of 
vitamin B12 concentration versus maximum cell density of BE86. The assay was linear from 
0 to 20 nM vitamin B12 with an r2 value of 0.9843. 
Growth of PduX Expression Strains. The E. coli strains used for expression of pduX 
were grown on 400 ml LB supplemented with 25 µg ml-1 kanamycin at 16°C in a New 
Brunswick Scientific, Innova 4230, refrigerated shaker- incubator with shaking speed at 275 
rpm. Cells were grown to an absorbance of 0.6–0.8 at 600 nm, and protein expression was 
induced by the addition of 0.5 mM IPTG. Cells were incubated at 16 °C with shaking at 275 
rpm for an additional 18 hours and harvested by centrifugation at 5000 × g for 10 minutes at 
4°C using a Beckman JA-10 rotor. 
Preparation of Cell Extract of Salmonella enterica. About 2.0 g of cell paste was 
suspended in 8 ml of 50 mM Tris (pH 7.5), 300 mM NaCl, 20 mM imidazole and broken by 
French pressure (Thermo Electron Corp.) at 20,000 psi. Pefabloc SC PLUS was added to the 
cell extract to a concentration of 100 µg ml-1 to inhibit proteases. The crude cell extract was 
centrifuged at 35000 × g for 30 minutes at 4°C using a Beckman JA-17 rotor to separate the 
soluble and insoluble fractions. The supernatant was the soluble fraction used for enzyme 
purification. 
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Purification of PduX-His6. Eight ml soluble cell extract from an E. coli expression strain 
was loaded onto a column containing 5 ml Ni-NTA Superflow resin (QIAGEN) previously 
equilibrated with 50 mM Tris (pH 7.5), 300 mM NaCl, 20 mM imidazole. The column was 
washed with 5 ml of 50 mM Tris (pH 7.5), 300 mM NaCl, 80 mM imidazole, then the 
enzyme bound to the column was eluted with 2.5 ml 50 mM Tris (pH 7.5), 300 mM NaCl, 
300 mM imidazole. The purified protein was desalted by using PD-10 desalting column (GE 
Healthcare Life Sciences) and eluted with 3.5 ml 10 mM Tris (pH7.5) following the 
manufacturer’s instructions. 
PduX Enzyme Assay. The activity of PduX was measured by using an ADP Quest assay 
kit according to the manufacturer’s instructions (DiscoverRx, Fremont, CA). The assay uses 
a coupled enzyme reaction system to generate hydrogen peroxide from ADP (ADP reacts 
with PEP to form pyruvate by pyruvate kinase, and then pyruvate oxidase generates 
hydrogen peroxide). Hydrogen peroxide when combined with Acetyl Dihydroxy 
Phenoxazine (ADHP) in the presence of peroxidase generates the fluorescently active 
resorufin dye. Standard assay mixtures contained 15 mM HEPES (pH 7.4), 20 mM NaCl, 10 
mM MgCl2 in a total volume of 0.1 mL. Activity was determined by monitoring the 
fluorescence intensity with a BioTek Synergy HT microplate reader. The excitation 
wavelength was 530 nm and emission wavelength was 590 nm. To minimize background 
fluorescence, 96-well black microplates were used (Greiner Bio-one, Frickenhausen, 
Germany). For kinetic studies, the concentrations of certain assay components varied as 
indicated in the text. Quantitation was based on standard curves made with ATP, GTP, CTP 
or UTP. 
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31P NMR Spectroscopy. The products of the PduX reaction were analyzed by 31P 
nuclear magnetic resonance (NMR) spectroscopy. Reactions were performed using 
conditions described for the PduX enzyme assay with 1 mg purified PduX-His6 in a final 
volume of 1 ml. The reaction mixtures were incubated at 37°C. Protein was removed by a 
Vivaspin 500, 10K filtration device. Samples were transferred to 5 mm NMR tubes 
(WILMAD). 50 µL 100% D2O was added (finally 5%). 31P NMR spectra of reference 
compounds and kinase reaction products were obtained with a 11.7-T magnet (Biomolecular 
Nuclear Magnetic Resonance Facility, Iowa State University, Ames) and a Bruker DRX 500 
spectrometer at the following settings: frequency, 202.347 MHz; excitation pulse width, 8.1 
µs; pulse repetition delay, 6 s; and spectral width, 12.136 kHz. Spectra were processed with 
TOPSPIN 1.3 software from Bruker. Chemical shifts were referenced to triphenyl phosphate, 
which was set to -18.0 ppm. 
High Pressure Liquid Chromatography (HPLC). A Mono Q HR5/5 column (GE 
Healthcare, Piscataway, NJ) was used with a Varian ProStar system that included a model 
230 solvent delivery module, a model 430 autosampler, and a model 325 UV-Vis detector 
(Varian, Palo Alto, CA). Buffers A and B contained 20 mM Tris (pH 8.0) and 50 mM and 1 
M NaCl, respectively. The flow rate was 1 ml min-1, and analytes were eluted with a linear 
gradient from 50 mM to 700 mM NaCl over 10 minutes. The compounds were monitered at 
260 nm. The retention times for ATP, ADP, GTP, GDP, UTP, UDP, CTP and CDP were 
4.46, 6.05, 5.18, 6.28, 4.37, 5.63, 4.09 and 5.47 min, respectively. 
Results 
PduX is Needed for Salmonella enterica Growth on 1,2-PD Minimal Medium 
Supplemented with Cby, but not on Similar Medium Supplemented with Cbi. L-Thr 
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kinase is predicted to be required for the synthesis of AdoCbl from Cby, but not from Cbi 
(Figure 3.1). Therefore, we measured aerobic growth of S. enterica and a pduX deletion 
mutant (BE892) on 1,2-PD minimal medium supplemented with Cby or Cbi. Under these 
conditions, growth requires the synthesis of AdoCbl from Cby or Cbi (15). 
Results showed that a pduX mutant was significantly impaired for growth on 1,2-PD 
minimal medium supplemented with Cby, but grew well on similar medium supplemented 
with Cbi (Figure 3.2). In contrast, wild-type S. enterica grew well on 1,2-PD medium 
supplemented with either Cby or Cbi. The generation times of S. enterica with Cbi and Cby 
were 4.2 and 5.8 hours, while those of the pduX mutant were 4.2 and 17.8 hours, 
respectively. These are the expected phenotypes of an L-Thr kinase mutant. Normal growth 
with Cbi indicates that the 1,2-PD degradative pathway is intact, and that corrinoid uptake is 
unimpaired since a single system is used for uptake of Cbi, Cby and other corrinoids (6-8). It 
also shows that pduX mutants can carry out all the steps needed for the conversion of Cbi to 
AdoCbl (Figure 3.1). Thus, the inability of pduX mutants to use Cby can be attributed to a 
defect in the conversion of Cby to AdoCbi-phosphate (Figure 3.1). This process requires four 
enzymes: 1. an adenosyltransferase (CobA); 2. an enzyme that converts AdoCby to 
AdoCbi-phosphate (CbiB); 3. an L-Thr-P decarboxylase (CobD) and 4. an L-Thr kinase (9, 
13, 22). The CobA, CbiB and CobD enzyme have been characterized in S. enterica (9, 13, 
22). Hence, the above studies suggest that PduX is an L-Thr kinase used for the conversion 
of Cby to AdoCbl. 
A PduX Deletion Mutation is Complemented by Ectopic Expression of PduX. A 
pduX expression plasmid (pLac22-pduX) was introduced into a pduX deletion mutant by 
electroporation. This plasmid fully corrected the growth defect of a pduX mutant on 1,2-PD 
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minimal medium supplemented with Cby (the generation time was 6.9 hours compared with 
6.1 hours for wild-type) (Figure 3.3). In contrast, plasmid without insert had little effect on 
growth (the generation time is 17.4 hours). This showed that the observed phenotype (poor 
growth with Cby) resulted from the pduX mutation but not from polarity or an unknown 
mutation. 
Supplementation of Growth Media with L-threonine-phosphate Substantially 
Corrects the Growth Defect of a PduX Mutant. In many cases, biosynthetic mutants are 
corrected by supplementation of growth medium with a downstream metabolite. Studies 
conducted here showed that 100 µM L-Thr-P substantially corrected the growth defect of a 
pduX mutant on 1,2-PD minimum media containing Cby (Figure 3.4). With 100 µM L-Thr-P 
the generation time for a pduX deletion mutant was 8.8 hours compared with a generation 
time of 8.3 hours for the wild-type strain. Both strains reached a maximum optical density at 
600 nm of about 0.4. These results indicate that PduX has a role in the synthesis of L-Thr-P. 
(R)-1-amino-2-propanol (AP) is Ineffective for Correction of a PduX Deletion 
Mutant. Prior studies showed that a cobD mutant was partly corrected for the synthesis of 
MeCbl from Cby by addition of AP to growth media (23). This and subsequent findings 
indicated that unknown kinase phosphorylated AP to AP-P bypassing the cobD defect 
(Figure 3.1) (13). Therefore, PduX was tested for AP kinase activity. However, results were 
negative. Both a cobD mutant and a pduX cobD double mutant grew similarly on minimal 
glucose medium supplemented with Cby and AP indicating that S. enterica converts AP to 
AP-P in the absence of PduX (Figure 3.9). Concentrations of AP between 1 mM and 20 mM 
were tested and in no case did the PduX+ strain grow better than the PduX- strain. The studies 
described above were conducted in a metE background under conditions where the 
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conversion of Cby to MeCbl is required for growth in minimal medium (24). Tests of PduX 
for AP kinase activity using 1,2-PD minimal medium supplemented with Cby and enzyme 
assays with purified recombinant enzyme were also negative. Thus, results indicate that 
PduX does not phosphorylate AP. 
PduX is Needed for Salmonella enterica Growth on Minimal Ethanolamine Medium 
Supplemented with Cby, but not on Similar Medium Supplemented with Cbi. The pduX gene 
is the last gene in the pdu operon (17). Measurable expression of this operon requires 1,2-PD 
(15, 25-27). This raised the question of whether PduX supports ethanolamine degradation. 
Results showed that a pduX mutant was unable to grow on ethanolamine minimal medium 
supplemented with Cby, but grew well on similar medium supplemented with Cbi (Figure 
3.5). In contrast, wild-type S. enterica grew well on ethanolamine medium supplemented 
with either Cby or Cbi. The generation times of S. enterica with Cbi and Cby were 4.3 and 
4.4 hours, while those of the pduX mutant were 4.3 and 33.1 hours, respectively. In addition, 
the growth defect of the pduX mutant on ethanolamine with Cby was fully corrected by 
ectopic expression of pduX, showing this defect resulted from the pduX mutation, but not 
from polarity or an unknown mutation. Hence, pduX is used for AdoCbl synthesis even in the 
absence of 1,2-PD which is required for transcription of the pdu operon (15, 17, 26, 27). This 
finding is surprising to us since it suggests that pduX has a different regulatory pattern than 
upstream genes presumed to be in the same operon. 
Thr-P but not AP Supplementation Allows Growth of a PduX Mutant on 
Ethanolamine with Cby. The growth defect of a pduX mutant on minimal ethanolamine 
medium supplemented Cby was corrected by addition of Thr-P, but not by addition of AP-P. 
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This was similar to results obtained with 1,2-PD (above) and provided further evidence that 
PduX is an L-Thr kinase. 
Production of MeCbl Sufficient to Support Methionine Biosynthesis is Independent 
of PduX. Salmonella enterica metE mutants require MeCbl for methionine biosynthesis; 
hence, L-Thr kinase should be required for growth of metE strains on minimal medium 
supplemented with Cby (Figure 3.1) (14). However, results showed that a metE pduX double 
mutant grew only slightly slower than wild-type on minimal glucose medium supplemented 
with Cby. Doubling times for the wild-type, metE mutant and metE pduX double mutant were 
2.0, 2.0 and 3.8 hours, respectively. This suggested that PduX contributed to MeCbl 
synthesis, but S. enterica also produced a second L-Thr kinase which allowed substantial 
growth of a metE mutant as is further explained in the discussion. 
PduX is Used for the De Novo Synthesis of B12. L-Thr kinase is expected to be required 
for the de novo synthesis of AdoCbl (Figure 3.1) (12). Therefore, we used a bioassay to 
quantitate de novo synthesis of AdoCbl and MeCbl by S. enterica, a pduX mutant and a cbiB 
mutant (as negative control). These strains produced B12 in the following amounts (pmole per 
gram wet cells): 2620 ± 112, 280 ± 11 and undetectable, respectively. Thus, a pduX mutant 
produced about 11% as much B12 as the wild-type strain. S. enterica BE86 was used for the 
bioassay. This strain grows on ethanolamine minimal medium supplemented with complete 
corrinoids such as AdoCbl and MeCbl, but not on similar medium supplemented with 
corrinoids such as AdoCby-P which might in a pduX mutant. 
High-level Expression of the PduX-His6 Protein. PduX with a 6× C-terminal His tag 
(PduX-His6) was produced at high levels via an E. coli T7 expression system and purified by 
Nickel-affinity chromatography (Figure 3.6). This procedure allowed the isolation PduX-His6 
 92
that appeared nearly homogeneous following Coomassie staining. The apparent molecular 
mass of PduX-His6 by SDS-PAGE was approximately 35 kDa which was close to the 
expected value of 33.7 kDa. 
ADP and L-threonine-O-3-phosphate are the Products of the PduX-His6 Reaction. 
31P NMR spectroscopy was used to identify the products of the PduX reaction. Figure 3.7A 
shows the 31P NMR spectrum of a kinase reaction mixture prior to addition of purified 
PduX-His6 enzyme. The triplet centered at -22.5 ppm corresponds to the β-phosphate of 
ATP; the two doublets centered at -7.1 ppm and -11.6 ppm correspond to the γ- and 
α-phosphates of ATP, respectively. Figure 3.7B shows the 31P NMR spectrum of ADP 
standard. The two doublets centered at -7.2 ppm and -11.2 ppm correspond to the β- and 
α-phosphates of ADP, respectively. Figure 3.7D shows the complete reaction mixture after 2 
hours of incubation at 37°C with 200 µg of purified PduX-His6. The triplet corresponding to 
the β-phosphate of ATP (-22.5 ppm) is absent. The two doublets centered at -7.2 ppm and 
-11.2 ppm of the complete reaction mixture correlate well with the two doublets of ADP 
standard (Figure 3.7B). The singlet at 2.3 ppm corresponds to the phosphate group of 
L-Thr-P (Figure 3.7C). Figure 3.7E shows the intermediate reaction mixture after 30 minutes 
of incubation at 37°C with 200 µg of purified PduX-His6. It shows clearly that the 
intermediate mixture contains L-Thr as well as both ATP and ADP (Figure 3.7F). Hence, 
these results indicate that ADP and L-Thr-P are the products of the PduX reaction. 
In Vitro Activity of PduX-His6. To test whether purified PduX-His6 had L-Thr kinase 
activity, we used a continuous fluorometric assay that measured the nucleoside diphosphate 
product (described in the experimental procedures section). With ATP as the substrate, the 
specific activity of purified PduX-His6 was 56.3 nmol min-1 mg protein-1. In the absence of 
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ATP, no activity was detected. In the absence of PduX, L-Thr or both, activity decreased by 
90%. The remaining 10% activity appears to have resulted from ATP-dependent background 
fluorescence. Thus, enzyme assays indicate that PduX has L-Thr kinase activity. 
Linearity and Nucleoside Triphosphates Specificity of the PduX Reaction. The 
fluorometric assay described above as well as an HPLC-based assay were used to determine 
the substrate specificity of PduX. Both assay methods gave similar results. Setting ATP to 
100%, the activity of PduX-His6 with CTP, GTP, or UTP was 6, 11, and 3 %, respectively, 
by the fluorometric method and 6, 12 and 4%, respectively, by HPLC assay. Assays 
contained 3 µM purified PduX-His6 and 200 µM nucleoside triphosphates. The effect of 
PduX concentration on enzyme activity was also determined. Results showed that the rate of 
reaction was proportional to PduX-His6 concentration from 0.006 to 6 µM when 200 µM 
ATP and 500 µM L-Thr were used as substrates. Linear regression yielded an r2 value of 
0.998. 
Km and Vmax Values for PduX. Purified PduX-His6 displayed Michaelis-Menten kinetics 
with respect to both ATP and L-Thr (Figure 3.8). Based on nonlinear regression, the Km 
values for ATP and L-Thr were 54.7 ± 5.7 µM, and 146.1 ± 8.4 µM, respectively. The 
enzyme Vmax was 62.8 ± 3.6 nmol min-1 mg protein-1 when L-Thr was varied and 61.4 ± 3.6 
nmol min-1 mg protein-1 when ATP was varied. The average of these two values is 62.1 ± 3.6 
nmol min-1 mg protein-1. Similar kinetic constants were derived from double-reciprocal plots: 
The Km values for ATP and L-Thr were 60.9 ± 9.7 µM and 127.0 ± 11.3 µM, respectively. 
Vmax values were 58.6 ± 6.2 nmol min-1 mg protein-1 when L-Thr was varied and 57.2 ± 5.8 
nmol min-1 mg protein-1 when ATP was varied. The average of these two values is 57.9 ± 6.0 
nmol min-1 mg protein-1. When the Km values for ATP were determined, saturating levels of 
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L-Thr (500 µM) were added to assay mixtures while varying the concentration of ATP. 
Similarly, saturating levels of ATP (200 µM) were added to assays when the Km values for 
L-Thr were determined. Purified PduX-His6 was used at a concentration of 3 µM. The values 
used for kinetic calculations were the average of three measurements of the initial reaction 
rate. 
Discussion 
Work done in a number of laboratories has defined many steps in the de novo synthesis of 
AdoCbl and MeCbl (3, 5, 28-32). Of particular relevance to this work are the studies reported 
by Brushaber et al. which showed the CobD enzyme catalyzes the decarboxylation L-Thr-P 
to AP-P (13). This finding predicted that B12 synthesis would require an L-Thr kinase. 
Subsequently, Rodionov et al. (18) proposed that PduX homologues might be L-Thr kinases 
involved in B12 synthesis. This was based sequence similarity to GHMP family of kinases 
and the observation that pduX genes were proximal to B12 biosynthetic genes in several 
instances. However, it is well-known that functional predictions based on sequence similarity 
and gene proximity are tentative. In addition, a number of PduX homologues are encoded by 
genes unlinked to B12 biosynthetic genes raising the possibility of functional diversity among 
PduX homologues. 
Here, we presented in vitro and in vivo evidence that the pduX gene of S. enterica 
encodes an L-Thr kinase involved in the de novo synthesis AdoCbl and the assimilation of 
Cby. 31P NMR spectroscopy indicated that purified PduX-His6 catalyzes the conversion of 
ATP and L-Thr to ADP and L-Thr-P (Figure 3.7). Enzyme assays indicated the ATP was 
preferred substrate for PduX compared to GTP, CTP and UTP. The Vmax of PduX (62 nmol 
min-1 mg protein-1) is within the range determined for other B12 biosynthetic enzymes which 
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have relatively low activity in accord with the low levels of AdoCbl and MeCbl that are 
required to support B12-dependent processes (5). The Km value of PduX for ATP (55 µM) is 
well below the ATP pool sizes in rapidly growing cells (1-3 mM) (33). The Km value for 
L-Thr (146 µM) is close to measured pool sizes (70-400 µM) for E. coli which is a close 
relative of S. enterica (34). Thus, in vitro studies demonstrated that purified recombinant 
PduX has L-Thr kinase activity with kinetic parameters suitable to a role in AdoCbl 
synthesis. 
In addition to the above in vitro studies, genetic tests demonstrated that PduX has a role 
in the synthesis of AdoCbl in vivo. A bioassay and growth tests showed that a pduX deletion 
mutant was impaired for the de novo synthesis AdoCbl and for the assimilation of Cby. In 
addition, the growth defects of a pduX mutant were corrected by addition of L-Thr-P to 
minimal media indicating that PduX is needed for L-Thr-P synthesis. 
A point of note is that bioassays found B12 in cultures grown under aerobic conditions. It 
is well-established that S. enterica only synthesizes B12 de novo in the absence of oxygen 
(35). The bioassays conducted here and unpublished studies done in our laboratory indicate 
that S. enterica synthesizes B12 under aerobic incubation conditions at high cell densities. 
Presumably, oxygen is depleted by cell respiration allowing B12 synthesis. This helps explain 
the paradoxical observation that S. enterica synthesizes B12 only in the absence of oxygen, 
but requires oxygen for degradation of ethanolamine and 1,2-PD as sole carbon and energy 
sources (5). 
The genetic tests performed here also indicated that a pduX mutant synthesized enough 
MeCbl to support substantial growth of a metE mutant. This suggests that S. enterica 
expresses an L-Thr kinase in addition to PduX, but raises the question why is this second 
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kinase unable to support ethanolamine or 1,2-PD degradation (Figures 3.2 and 3.5). One 
explanation is that the second kinase is induced during growth on glucose. Alternatively, the 
activity of the second kinase might be insufficient for 1,2-PD and ethanolamine degradation. 
A pduX mutant grew slowly on 1,2-PD minimal medium supplemented with Cby (Figure 
3.2) suggesting a second kinase with low activity. Prior studies showed that the MeCbl 
needed to support growth of a metE mutant (methionine biosynthesis) was about 100-fold 
less than the amount of AdoCbl needed to support 1,2-PD and ethanolamine degradation. 
Hence, a second L-Thr kinase that has low activity compared to PduX is indicated. 
To our knowledge, PduX is the first enzyme reported to transfer a phosphoryl-group to 
free L-Thr. Sequence similarity indicates that PduX is a member of the GHMP kinase family 
(18). This family includes members that transfer the γ-phosphoryl-group of ATP to acceptors 
such as mevalonate, homoserine, galactose, and developmental protein Xol-1 (36). A feature 
of PduX we think is interesting is that it phosphorylates free L-Thr which is also required for 
protein synthesis. Presumably, PduX would need to be regulated to prevent L-Thr depletion 
or a futile cycle that needlessly consumes ATP. However, regulation of the activity of the 
PduX enzyme has not been studied. 
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TABLE 3.1 Bacterial strains used in this study 
 
Species and strain      Genotype 
Escherichia coli 
DH5α...................F- λ- endA1 hsdR17 relA1 supE44 thi-1 recA1 gyrA96 relA1 
∆(lacZYA-argF)U169 (φ80dlacZ∆M15) 
BL21DE3 RIL.....F- ompT hsdS (rB- mB-) dcm+ Tetr gal λ(DE3) endA Hte [argU ileY leuW 
Camr] 
BE119…………...BL21DE3 RIL/pTA925  
BE945…………...DH5α/pTA925 -pduX-His6 
BE963…………...BL21DE3 RIL/ pTA925-pduX-His6 
 
Salmonella enterica serovar Typhimurium LT2 
BE86…………….DEL1715[(cbiD24)*MudJ*(zea-3666)] 
BE200…………...Del pduX668 
BE287…………...pLac22 
BE438…………...cbiB24::mudJ 
BE892…………...Del pduX685::Kan  
BE933…………...Del pduX685::kan/pLac22 
BE935…………...Del pduX685::Kan/pLac22-pduX  
BE938…………...Del pduX668 cobD498::mudJ 
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Figure 3.1 Pathways for assimilation of Cbi and Cby in Salmonella enterica. AdoCbl and 
MeCbl are the forms of B12 that function as enzymatic cofactors. The assimilation of Cbi and 
Cby and the later steps of the de novo synthesis of the B12 coenzymes share a number of 
enzymatic steps. A key difference is that the conversion of L-Threonine-O-3-phosphate to 
(R)-1-amino-2-propanol-O-2-phosphate is unnecessary for the assimilation of Cbi. 
Abbreviations: Btu, B12 uptake system; Cbi, cobinamide; Cby, cobyric acid; AdoCbi, 
adenosylcobinamide; AdoCby, adenosylcobyric acid; AdoCbi-P, adenosylcobinamide 
phosphate; AdoCbl, adenosylcobalamin; MeCbl, methylcobalamin; L-Thr, L-threonine; 
L-Thr-P, L-threonine-O-3-phosphate; AP-P, (R)-1-amino-2-propanol-O-2-phosphate. 
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Figure 3.2 Effects of a pduX deletion on 1,2-propanediol degradation with Cbi or Cby. 
Cells were grown in minimal 1,2-propanediol medium supplemented with 50 nM Cbi or Cby. 
Solid triangle: BE892 (Del pduX) with Cbi; Open diamond: wild-type with Cby; Open 
triangle: BE892 (Del pduX) with Cby. 
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Figure 3.3 Complementation of the pduX deletion by ectopic expression of by pduX. Cells 
were grown in minimal 1,2-propanediol medium supplemented with 50 nM Cby. Open 
diamond: wild-type S. enterica; Solid triangle: BE935 (Del pduX/pLac22-pduX); Open 
triangle: BE933 (Del pduX /pLac22). 
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Figure 3.4 Effects of L-threonine phosphate on growth of a pduX deletion. Cells were 
grown in minimal 1,2-propanediol medium supplemented with 50 nM Cby and 100 µM 
L-Thr-P. Solid diamond: wild-type S. enterica; Open triangle: BE892 (Del pduX). 
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Figure 3.5 Effects of a pduX deletion on ethanolamine degradation with Cbi or Cby. Cells 
were grown in minimal ethanolamine medium supplemented with 50 nM Cbi or Cby. Solid 
triangle: BE892 (Del pduX) with Cbi; Open diamond: wild-type with Cby; Open triangle: 
BE892 (Del pduX) with Cby. 
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Figure 3.6 SDS-PAGE analysis of PduX-His6 purification. Lane 1, molecular mass 
markers; Lane 2, 5 µg of soluble extract of strain BE963 (PduX-His6); Lane 3, 5 µg of flow 
through fraction; Lane 4, 5 µg of 80 mM imidazole wash fraction; Lane 5, 5 µg of 300 mM 
imidazole elution fraction. The gel contained 12% acrylamide and was stained with 
Coomassie Brilliant Blue. 
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Figure 3.7 31P NMR spectra of a PduX reaction. (A) Reaction mixture containing 1 mM 
ATP and 1 mM L-threonine prior to addition of enzyme. (B) ADP standard (1 mM) (C) 
L-threonine-O-3-phosphate standard (1 mM). (D) Complete reaction after 2 hours of 
incubation with 200 µg of purified PduX-His6. (E) Intermediate reaction after 30 minutes of 
incubation with 200 µg of purified PduX-His6. (F) Expanded view of intermediate reaction 
from chemical shift -7.0 to -12.0 ppm. The chemical shifts observed were -7.1 ppm, -11.6 
ppm, and -22.5 ppm for the γ-, α-, and β-phosphates of ATP, respectively, -7.2 ppm and 
-11.2 ppm for the β- and α-phosphates of ADP, respectively, and 2.3 ppm for 
L-threonine-O-3-phosphate. All chemical shifts are referenced to triphenyl phosphate, which 
was set to -18.0 ppm. 
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Figure 3.8 Kinetic analyses of PduX. Enzyme assays were performed with 3 µM purified 
PduX-His6 protein. When the Km value for ATP was determined, L-threonine was held at 500 
µM and the concentration of ATP was varied. When the Km value for L-threonine was 
determined ATP was held at 200 µM and the concentration of L-threonine was varied. The 
values shown are the average of three measurements of the initial reaction rate. The Insets are 
the double-reciprocal plots of the kinetic data. 
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Figure 3.9 Effects of (R)-1-amino-2-propanol (AP) on growth of a pduX deletion. Cells 
were grown in minimal 1,2-propanediol medium supplemented with 50 nM Cby and 20 mM 
AP. Solid diamond: wild-type S. enterica; Open diamond: Del pduX; Closed diamond: Del 
pduX cobD. 
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CHAPTER 4 KINETIC AND FUNCTIONAL ANALYSIS OF L-THREONINE 
KINASE, THE PDUX ENZYME OF SALMONELLA ENTERICA 
A paper in preparation 
Chenguang Fan, Herbert J. Fromm and Thomas A. Bobik 
Abstract 
The PduX enzyme of Salmonella enterica is an L-threonine kinase used for the de novo 
synthesis of coenzyme B12 and the assimilation of cobyric acid. PduX with an N-terminal 
histidines tag (His8-PduX) was produced in Escherichia coli and purified. The recombinant 
enzyme was soluble and active. Kinetic analysis indicated an ordered ternary complex 
mechanism in which ATP is the first substrate to bind. The lack of obvious pH and isotope 
effects indicated that proton transfer is unlikely to be involved directly in the rate 
determining step of catalysis. Based on a multiple sequence alignment of PduX homologues 
and other GHMP family members, 14 PduX variants having changes at 10 conserved 
serine/threonine and aspartate/glutamate sites were constructed by site-directed mutagenesis. 
Each variant was produced in E. coli and purified. Comparison of the CD spectra and kinetic 
properties of the PduX variants to those of the wild-type enzyme indicated Glu-24 and 
Asp-135 are needed for proper folding, Ser-99 and Glu-132 are used for ATP binding, 
Ser-253 and Ser-255 are critical L-threonine binding while Ser-100 is essential to catalysis 
but it's precise role is uncertain. To our knowledge, the studies reported here are the first to 
investigate the catalytic mechanism of L-threonine kinase from any organism. 
Introduction 
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The B12 coenzymes (adenosylcobalamin, AdoCbl, and methylcobalamin, MeCbl) are the 
largest cofactors known in biology. They are essential for the human health and have 
important metabolic roles in many microbes (1,2). The B12 coenzymes are synthesized de 
novo by certain prokaryotes and from corrinoid precursors by a broader range of organisms 
(1,2). The synthesis of B12 has been studied extensively in Salmonella enterica (3,4). This 
organism carries out de novo synthesis under anaerobic conditions and assimilates corrinoids 
such as cobinamide (Cbi) and cobyric acid (Cby) under both aerobic and anaerobic 
conditions (3,5). We recently showed that the PduX enzyme of S. enterica is a L-threonine 
kinase, which is required for the de novo synthesis of AdoCbl and MeCbl, and the 
assimilation of Cby (6). By sequence similarity, the PduX enzyme in Salmonella enterica 
belongs to GHMP (galactokinase, homoserine kinase, mevalonate kinase, and 
phosphomevalonate kinase) family (7), which is a novel family of kinases found in metabolic 
pathways of small molecules. Although there has been no three-dimensional structure of 
PduX or other L-threonine kinases reported to date, the crystal structures of several GHMP 
kinases have been solved (8-15) (16-19) (20,21) (22). These structures reveal a unique kinase 
fold and a novel nucleotide-binding mode that are conserved among members of the GHMP 
kinase family. All members contain three common motifs (23). Motif I is at the N-terminal 
region and its function is uncertain. Motif II is the most conserved one with a typical 
sequence Pro-X-X-X-Gly-Leu-X-Ser-Ser-Ala. This region is involved in nucleotide binding 
and distinguishes the GHMP family from other protein kinase families. Motif III is near the 
C-terminus containing a small glycine-rich loop that appears well-positioned to interact with 
substrate that is phosphorylated by ATP (24). However, there are highly divergent sequences 
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outside these three motifs and modes of oligomerization, substrate-binding and catalytic 
mechanism vary among different members (14). 
Based on structural and biochemical data, members of GHMP family are subdivided into 
two groups depending on their catalytic mechanisms. In the first group, which includes rat 
mevalonate kinase, the crystal structure shows an aspartate residue in the active site 
positioned to act as a catalytic base that abstracts a proton from substrate hydroxyl group. In 
addition, there is a lysine residue that is thought to reduce the pKa of the substrate hydroxyl 
group and to stabilize the penta-coordinated γ-phosphoryl group of ATP (18). In the second 
group, such as Escherichia coli homoserine kinase, there appears to be no suitable residue 
positioned to act as a catalytic base. Consequently, it has been hypothesized that homoserine 
kinase achieves catalysis through transition state stabilization alone (14). 
Here, we investigate the catalytic mechanism of PduX by a series of kinetic studies and 
mutational analyses of 10 invariant serine/threonine and aspartate/glutamate residues. Results 
indicate an ordered ternary complex mechanism in which ATP binds first and a catalytic 
mechanism that involves primarily transition state stabilization, rather than acid-base 
catalysis. To our knowledge these are the first reported studies on the catalytic mechanism of 
L-threonine kinase from any organism. 
Experimental Procedures 
Chemicals and Reagents. Adenylyl imidodiphosphate (AMP-PNP), L-threonine 
phosphate, nucleoside triphosphates and nucleoside diphosphates were purchased from 
Sigma-Aldrich (St. Louis, MO). Restriction enzymes and T4 DNA ligase were from New 
England Biolabs, Beverly, MA. Pefabloc SC PLUS was purchased from ICN Biomedicals 
Inc. (Aurora, OH). Other chemicals were from Fisher Scientific (Norcross, GA). 
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Cloning Expression and Purification of His8-PduX. PCR was used to amplify the pduX 
coding sequence from pEM55 (25). The forward primer for fusing eight histidines to the 
N-terminus was 5’-GCC GCC AGA TCT TAT GCA CCA TCA CCA TCA TCA CCA CCA 
TCG CGC ACA CTA TTC GTA CC-3’. The reverse primer was 5’-GCC GCC AAG CTT 
ATC ACT GCA GTT TGA CCC CGC C-3’. The cloning procedure and the protein 
production and purification procedure were carried out as previously described (6). 
Kinase activity assay. The activity of PduX was measured by using an ADP Quest assay 
kit according to the manufacturer’s instructions (DiscoverRx, Fremont, CA) as previously 
described (6). To minimize background fluorescence, 96-well black microplates were used 
(Greiner Bio-one, Frickenhausen, Germany). For kinetic studies, the concentrations of certain 
assay components were varied as indicated in the text. All data were analyzed by nonlinear 
curve fitting using the program GraFit (Erithacus Software Limited). 
 Site-Directed Mutagenesis of His8-PduX. Mutations were introduced into the 
His8-PduX-pTA925 (6) construct using the QuikChange II-E Site-Directed Mutagenesis Kit 
(Stratagene). Briefly, PCR was used to amplify the entire plasmid from two complementary 
primers which both contained the desired mutation. The template plasmid was then digested 
with Dpn I and transformed into E. coli XL-1 Blue. Pure cultures were prepared from 
selected transformants and the plasmids were purified. Clones with the expected DNA 
sequence were used for further study. All mutant PduX proteins were produced and purified 
by the same method as the wild-type. 
Circular Dichroism (CD) spectra. CD spectra of the mutants used in this study were 
collected using a Jasco J-710 spectropolarimeter (cell length = 1 cm). The samples contained 
enzyme (4.0 µM) and K2HPO4 (10 mM), pH 8.4. CD data were collected from 190 to 250 nm 
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with scanning speed 50 nm/min, resolution 0.2 nm, band width 1.0 nm, sensitivity 20 mdeg 
and response 8 seconds at room temperature. CD data were analyzed by program JFIT. 
DNA sequencing. DNA sequencing was carried out by Iowa State University, DNA 
facility of Iowa State University Office of Biotechnology using automated sequencing 
equipment from Applied Biosystems Inc. 
Results 
The PduX L-threonine kinase reaction proceeds via an ordered, ternary complex 
mechanism. For a bi-substrate reaction, there are two classes of kinetic mechanisms: one 
involves a ternary complex of both substrates and the enzyme, and the other is the ‘Ping 
Pong’ mechanism (26). In the ‘Ping Pong’ model, one substrate binds to the enzyme, 
undergoes some forms of chemical change such as covalent modification of the enzyme, then 
the first product is released and the second substrate binds, often receiving the chemical 
group from the enzyme. A diagnostic feature of this mechanism is that when the 
concentration of one substrate is fixed and the other varied, a double reciprocal plot of rate 
versus concentration of the variable substrate will be parallel with similar plots at different 
fixed substrate concentrations (26,27). Kinetic analyses of His8-PduX showed that such lines 
converged and were not parallel excluding the ‘ping-pong’ mechanism (Figure 4.1). Hence, 
the PduX reaction most likely proceeds via a ternary complex mechanism in which the 
enzyme binds to both substrates before a chemical reaction occurs. There are three possible 
ternary complex mechanisms, one random and two ordered. In a random mechanism either of 
the substrates may bind first, and the binding of one does not influence the binding of the 
other. In an ordered mechanism, one substrate must bind first and this binding is a 
pre-requisite for interaction with the second substrate (27). 
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Studies of product inhibition can provide information about the order of substrate 
binding (26,28). Therefore, we examined the effect of L-threonine-O-phosphate on the PduX 
reaction over a range of concentrations (Figure 4.2). L-threonine phosphate is noncompetitive 
versus both ATP and L-threonine. If the reaction proceeded by a random mechanism, 
L-threonine-O-phosphate would be a competitive inhibitor of both substrates. Hence, a 
random ternary complex mechanism is rejected and an ordered mechanism inferred. 
Competitive inhibition is also observed in an ordered mechanism between the final product 
released and the first substrate to bind since both interact with the same form of the enzyme 
(27). Since L-threonine-O-phosphate was a noncompetitive inhibitor with respect to both 
L-threonine and ATP as shown, we conclude that L-threonine-O-phosphate is the first 
product released. This means that ADP must be the second product to be released and 
symmetry suggests that ATP is the first substrate bound. 
The effects of the other product of the PduX reaction (ADP) as an inhibitor could not be 
assessed using the coupled enzyme assay system since ADP is a substrate for the coupling 
enzyme. However, competitive dead-end inhibitors, which block binding of one substrate to 
the active site, are also useful for determining the binding order. If such an inhibitor is 
competitive with substrate A and uncompetitive with substrate B, then A is second to bind 
(26). Here, we used AMP-PNP as a competitive dead-end inhibitor versus ATP. Inhibition by 
AMP-PNP was determined over a range of AMP-PNP concentrations while varying the ATP 
concentration with L-threonine at saturating levels and vice versa (Figure 4.3). AMP-PNP is 
competitive versus ATP and noncompetitive versus L-threonine. We also used L-valine as a 
dead-end analog versus L-threonine (Figure 4.4). L-valine is an uncompetitive inhibitor 
versus ATP and a competitive inhibitor versus L-threnine. Thus, studies using AMP-PNP and 
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L-valine as dead-end inhibitors support the product inhibition studies using 
L-threonine-O-phosphate which also indicated that ATP is the first substrate to bind to PduX. 
Controls established that AMP-PNP inhibition of pyruvate kinase, which was the coupling 
enzyme used in these studies, was not significant and did not influence the rate 
measurements. 
Effect of pH on PduX activity. To investigate a possible role for ionizable residues in 
the pduX reaction mechanism, we examined kinetic parameters as a function of pH (Figure 
4.5). The reaction buffer system was composed of MES, HEPES, CHES or a mixture of 
buffers (total of 100 mM) with 100 mM KCl and 10 mM MgCl2 with pH range from 5.5 to 
9.0. This is the pH range in which the PduX is stable and soluble. The buffer components 
were examined separately and had no effect on the enzyme activity. The pH values of the 
buffers were determined before the addition of 20% (v/v) dimethylsulphoxide (DMSO), a 
water miscible aprotic solvent. The apparent kcat profile has a maximum from pH 7 to 8.5, but 
no dramatic changes were observed on either side (The lowest value was only 14% less than 
the maximum value.). The apparent specificity constants also varied little with pH. The pKa 
of ionizable groups depends upon the dielectric constant of the solvent. Altering the polarity 
of the solvent can therefore alter the pKa values of groups in enzyme active sites. The pH 
profile for PduX was repeated in the presence of 20% DMSO. The apparent kcat values 
showed the same trend but were about 10% lower compared to values obtained in the 
absence of DMSO. The apparent specificity constants showed little variation over the pH 
range examined (Figure 4.5). Hence, ionizable groups do not appear to participate directly in 
catalysis. 
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Isotope effects on PduX activity. Solvated deuterons have substantially different 
physical properties than protons. Substituting deuterium oxide for water in an enzyme 
reaction can thus provide information whether proton transfer is involved in the reaction. The 
effects of adding increasing amounts of deuterium oxide on the kinetic parameters of PduX 
were determined at pH 8.0 (Figure 4.6). There was a very small of linear decrease in apparent 
turnover numbers as the mole fraction of deuterium oxide increased. There was no obvious 
effect on the specificity constants for either substrate. Thus, proton transfer does not appear 
to be critical to the PduX catalytic mechanism. 
Selection of Mutagenesis Targets. The choice of the appropriate amino acid targets for 
site-directed mutagenesis was based on sequence comparisons among related enzymes and 
previous mutation analysis on other members of GHMP family (29-32). Highly conserved 
residues in all members of GHMP family are likely to participate in the common steps of 
catalysis, while residues that are conserved within one family but are different in others are 
candidates for specific interactions with the substrates. The amino acid sequences of PduX 
homologues (that are annotated as functioning in B12-dependent 1,2-propanediol degradation) 
from various species were aligned by using the ClustalX program. Four highly conserved 
motifs were identified (Figure 4.7). Motif I of PduX occurs in approximately the same place 
as the non-ATP substrate binding site in the other family members but the sequence is quite 
different. Therefore, motif I of PduX may form part of the L-threonine-binding site. Motif II 
is well-conserved throughout the GHMP family (equivalent to Motif II in GHMP family) and 
interacts with the phosphates of ATP. Motif III is also well-conserved across the GHMP 
family (equivalent to Motif III in GHMP family) and is close to the substrate binding sites. 
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Motif IV is unique to PduX. Since it is near the ATP-binding motif, it is possible that this 
motif forms part of the active site or ATP-binding site. 
The catalytic function of carboxylate side chains in phosphotransferase reactions has been 
well documented for several GHMP family enzymes (29,32). In view of these results, we 
investigated two conserved glutamates (Glu-24 and Glu-132) and two invariant aspartates 
(Asp-103 and Asp-135) that are located in highly conserved motifs (Figure 4.7). Each residue 
was replaced with alanine and its isosteric substitution (glutamine replaces glutamate and 
asparagine replaces aspartate). 
There is also precedent for participation of hydroxyl groups from serine or threonine in 
substrate binding and/or catalysis in GHMP family members (14,18,30,31). A proposed 
mechanistic role for such residues is H-bonding to oxygen atoms of the ATP phosphoryl 
chain (9,18,21). Elimination of side chains that function in phosphoryl chain orientation by 
hydrogen-bonding interactions can correlate with large diminutions in catalytic rate (30,31). 
From sequences alignment we found four invariant serine residues (Ser-99, Ser-100, Ser-253, 
and Ser-255) and two conserved threonines (Thr-101 and Thr-134) in highly conserved 
motifs (Figure 4.7). We replaced these residues with alanines. 
Structural integrity of PduX variants. We used CD spectra to detect protein secondary 
structure changes caused by amino acid replacements. CD data were analyzed and fitted by 
JFIT program. The wild-type CD spectrum shows the PduX has 67.01% helical, 19.30% 
sheet and 13.69% coil structure (Figure 4.8). This result is consistent with the previously 
solved crystal structures of GHMP family kinases which contain large proportion of helical 
structures (9,17,18). The CD spectra of the PduX variants were compared to that of the 
wild-type enzyme (Table 4.1). Mutations E24A and D135A resulted in a large decrease in 
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helical structure (E24A drops to 54.27% and D135A decreases to 48.05%) indicating that 
these two conserved sites might be involved in proper folding of PduX enzyme. Other PduX 
variants showed no obvious changes in the CD spectra indicating that the mutations did not 
lead to major changes in folding. 
Kinectic Characterization of PduX mutants. Using purified enzymes, kinetic 
constants were determined for the wild-type and mutant PduX enzymes. Km and kcat values 
were determined by nonlinear regression with Grafit (Table 4.2). When the Km values for 
ATP were determined, saturating levels of L-threonine (5 mM) were added to assay mixtures 
and the ATP concentration was varied from 0 to 500 µM. Similarly, saturating levels of ATP 
(2 mM) and varying levels of L-threonine from 0 to 500 µM were used to determine the Km 
values for L-threonine. 
 Three mutants (E24A, S100A and D135A) had no activity even with saturating levels of 
both substrates (ATP 2 mM, L-threonine 5 mM), so their kinetic parameters could not be 
determined. Two of these (E24A and D135A) had abnormal CD spectra indicating improper 
folding. Six mutants (E24Q, T101A, D103A, D103N, T134A and D135N) had kinetic 
parameters similar to those of wild-type PduX. The remaining five mutants had altered 
kinetic properties compared to wild-type PduX. Mutations S253A and S255A increased the 
Km for L-threonine more than 30-fold indicating that these residues may be involved in 
binding of L-threonine. Mutations S99A, E132Q, and E132A, had Km values for ATP more 
than 20-fold higher than wild-type indicating a possible role in ATP binding. 
Discussion 
Previous studies of GHMP family members have revealed three kinetic mechanisms, 
depending on the enzyme. The first group uses an ordered mechanism in which ATP was the 
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first substrate to bind including galactokinase from rat liver (33), yeast (34), and human (35), 
and homoserine kinases from E. coli (36), and Methanococcus jannaschii (37). The second 
group appears to have an ordered mechanism in which the non-ATP substrate binds first 
including broad bean galactokinase (38) and hog liver mevalonate kinase (39). The last group 
was shown to proceed by a random ternary complex mechanism such as E. coli galactokinase 
(40) and Streptococcus pneumoniae phosphomevalonate kinase (41). It is interesting that 
GHMP family members use different kinetic mechanisms despite the existence of highly 
similar primary structures. This suggests that this superfamily interacts with their substrates 
using similar chemical functions, but that their dynamics are quite different. The studies of 
PduX L-threonine kinase presented here are consistent with an ordered ternary complex 
mechanism in which ATP binds first and L-threonine second. The most likely explanation for 
an ordered mechanism is that the binding of the first substrate induces a conformational 
change in the enzyme resulting in the formation of a high-affinity binding site for the second 
substrate. 
We also determined the effects of pH and deuterium oxide on the kinetic parameters of 
PduX. pH-dependent changes in the apparent kcat/Km reveals information concerning changes 
in the state of ionization of essential functional groups on the enzyme or substrates that affect 
activity, while the apparent turnover numbers profile reflects changes in the state of 
ionization of groups on the central enzyme–substrate complexes. For PduX enzyme, a small, 
pH-dependent effect on the apparent turnover number was measured. However, this effect 
was much smaller than expected if a pH-sensitive group was involved directly in catalysis in 
which case at least one unit difference on log scale is expected (26,27). Similarly, only a 
small kinetic isotope effect on kcat was observed with deuterium oxide. We conclude that this 
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was due to an indirect effect on catalysis rather than an effect on a critical proton transfer 
event that drives the reaction. The apparent specificity constants for ATP and L-threonine 
were essentially unaffected over the pH range used in our experiments. They were also 
unchanged in the presence of DMSO and no solvent kinetic isotope effect was observed for 
either kcat or kcat/Km. This indicates that there are no critical ionizable residues involved in the 
interaction of the free enzyme with ATP or in the interaction between the enzyme–ATP 
complex with L-threonine. 
Within the GHMP kinase family, different members use different catalytic mechanisms. 
Studies on mevalonate kinase and phosphomevalonate kinase have suggested a mechanism 
involving a conserved aspartic acid residue as a possible catalytic base whose role is to 
activate the acceptor hydroxyl group of the substrate. A conserved lysine residue near the 
acceptor hydroxyl group is proposed to lower its pKa facilitating proton abstraction 
(15,17,18,24). In contrast, in homoserine kinase, no strong nucleophile sits near the acceptor 
hydroxyl group. Phosphoryl transfer in homoserine kinase has been suggested to occur by 
direct nucleophilic attack on the γ-phosphate group of ATP by the δ-hydroxyl of homoserine 
(14). In this mechanism, homoserine is stabilized by the formation of a hydrogen bond to 
asp-141, which is not conserved in the superfamily. The side chain hydroxyl group of thr-183 
interacts with the β-phosphate of the nucleotide and thus may help to stabilize the transition 
state (14). In another GHMP member, galactokinase, there is a conserved asp-83 that may 
serve to abstract the proton from the hydroxyl group of galactose for its subsequent attack on 
the γ-phosphorus of ATP. Additionally, there is an arg-36 residue that corresponds to the 
lysine in mevalonate kinase which is hypothesized to lower the pKa of the substrate hydroxyl 
group (8). However, kinetics studies on the galactokinase showed little variation in the 
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turnover number and specificity constants with respect to pH and negligible effects on 
addition of increasing mole fractions of deuterium oxide in place of water (34,35). Hence, 
there is a controversy as to whether the conserved aspartate in galactokinase functions as a 
catalytic base or rather is simply involved in substrate binding (10). Our studies on the effects 
of pH and deuterium oxide on the kinetics of PduX indicated that this enzyme is similar to 
homoserine kinase which lacks a catalytic base in the active site, and that it probably derives 
its catalytic power from its ability to stabilize the transition state. 
Most of our understanding of the catalytic mechanisms of GHMP family members comes 
from the analysis of crystal structures with substrates or substrate analogs bound. Only 
limited mutagenesis data are available on the roles of key functional groups (29,42-44). Here, 
we changed ten highly conserved amino acids of PduX, which have carboxylate- or 
hydroxyl-containing side chains, and tested the effect of these mutations on structure and 
kinetic parameters. Our alignment results showed there are four highly conserved motifs in 
PduX homologues. In motif I, Glu-24 is the only invariant residue and it is also well 
conserved in the GHMP family. The replacement of Glu-24 with alanine resulted in large 
secondary structure changes (about 30 amino acids changed from a helical structure to 
random coil) and complete loss of activity. Since alanine has a small side chain without any 
charge or polarity, we made the isosteric substitution of glutamine for Glu-24. This mutant 
had almost the same secondary structure and similar kinetic behavior to wild-type, with only 
2-fold decrease in specific activity and modest increase in apparent Km values for both 
substrates (2-fold increase for ATP and 3.5-fold increase for L-threonine). These results 
indicated Glu-24 is probably involved in folding rather than having a direct role in catalysis. 
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Motif II is the most highly conserved motif in the GHMP family. It forms a distinct ATP 
binding loop not found in other kinase families (23). In this motif, we mutated four sites: 
Thr-101 and Asp-103 which are only highly conserved in PduX homologues and Ser-99 and 
Ser-100 which are conserved across the entire GHMP family. None of these mutations 
caused an obvious change in secondary structure based on CD analyses. T101A showed only 
a 15% decrease in apparent turnover number and approximately a 2-fold increase in Km for 
both ATP and L-threonine. Replacement of Asp-103 with alanine or asparagine did not cause 
a significant change in kinetic parameters. It seems that Thr-101 and Asp-103 have no key 
function in substrate binding or catalysis even though they are conserved among PduX 
homologues. In contrast, mutant S99A had a 25-fold higher Km for ATP, a 1.4-fold higher Km 
for L-threonine and 1.2-fold decrease in kcat indicating that Ser-99 is involved in ATP 
binding. Mutant S100A had no activity at all even with 2 mM ATP (40-fold Km,ATP for 
wild-type). Hence, we propose a critical role of the hydroxyl group of Ser-100 in catalysis of 
the PduX reaction. Ser-100 of PduX corresponds to Ser-145 in human and Ser-121 in yeast 
mevalonate diphosphate decarboxylase. Previous mutagenesis analysis of human mevalonate 
kinase proposed Ser-145 functions also as a hydrogen bond donor to a phosphoryl oxygen of 
bound substrate or product nucleotide (30). In yeast mevalonate diphosphate decarboxylase 
they proposed that Ser-121 functions in orienting the phosphoryl chain to optimize the angle 
of attack on the γ-phosphate of ATP (31). We propose that Ser-100 could interact with 
γ-phosphate of ATP to stabilize the transition state of the reaction corresponding to Thr-183 
in homoserine kinase which has a similar catalytic mechanism to PduX (14). However, an 
understanding of exact function of Ser-100 in the PduX L-threonine kinase reaction will 
require further. 
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Mutagenesis was also used to examine the function of conserved motif III in PduX. 
S253A and S255A both showed large increases in apparent Km values for L-threonine 
(37-fold and 29-fold individually). Since both substitutions had no major impact (less than 
2-fold) on turnover rates or the specificity constants for ATP, the large increase in Km,L-Thr 
reflects a significant diminution in L-threonine binding efficiency. 
Motif IV is conserved only in the PduX homologues but the specific sites within this 
motif that were changed for this study are also well-conserved across the GHMP family. 
Several crystal structures of GHMP members show a glutamate residue, corresponding to 
Glu-132 in PduX, coordinates with Mg2+ ion thus activates the γ-phosphate of ATP 
(14,15,18). When we changed glutamate 132 of PduX to alanine or glutamine, the Km value 
for ATP increased 37-fold and 23-fold respectively, with only minor (less than 1.5-fold) 
change in the kcat or the kcat/Km for L-threonine. The T134A mutation had little effect on the 
kinetics of PduX. Motif IV also contains conserved residue Asp-135. As mentioned above, 
there are two branches of GHMP kinase family, distinguished by the presence or absence of 
an aspartate residue that plays a role as a catalytic base. In homoserine kinase subfamily, this 
aspartate residues is absent (14). However, in mevalonate kinase and phosphomevalonate 
kinase subfamilies, both crystal structures and mutagenesis indicated that this aspartate 
functions as a catalytic base (15,17,18,24,29,32). In the case of PduX, replacement of 
Asp-135 with alanine caused loss of both structural integrity and enzyme activity, while 
substitution with asparagine had little effect (only 2-fold decrease in apparent specificity 
activity). Hence, in PduX, Asp-135 appears to have primarily a structural role. 
In summary, the four conserved motifs in PduX subfamily play different roles in the 
phosphoryl-transfer process. Motifs II and IV are mainly for ATP binding while motif III is 
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for L-threonine binding. Glu-24 and Asp-135 are needed for proper folding. Collectively, the 
studies presented here help to define catalytic mechanism of L-threonine kinase, a key 
enzyme in the de novo synthesis of coenzyme B12 and further expand our understanding of 
the catalytic properties of the GHMP superfamily. 
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Table 4.1 Circular Dichroism (CD) Fitted Data for PduX Mutants 
 Helix % Sheet % Coil % R factor % 
Wild-type 67±5 19±3 14±3 9±2 
E24Q 64±5 20±3 15±3 6±2 
E24A 54±4 19±3 27±4 8±2 
S99A 66±5 20±3 14±3 7±2 
S100A 65±5 26±3 9±2 7±2 
T101A 68±5 22±3 9±2 7±2 
D103N 63±5 21±3 16±3 7±2 
D103A 65±5 21±3 14±3 8±2 
E132Q 68±5 22±3 10±2 9±2 
E132A 68±5 16±3 16±3 9±2 
T134A 67±5 24±3 9±2 7±2 
D135N 64±5 20±3 17±3 9±2 
D135A 48±4 22±3 30±3 8±2 
S253A 66±5 24±3 10±2 8±2 
S255A 66±5 18±3 16±3 8±2 
The values shown are based on three replicates. 
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Table 4.2 Kinetics Constants for PduX Mutants a 
 
Km,ATP       
(µM) 
Km,L-Thr    
(µM) 
kcat,ATP  
(min-1) 
kcat,L-Thr  
(min-1) 
kcat /Km,ATP 
10-4(µM-1 min-1) 
kcat /Km,L-Thr 
10-4(µM-1 min-1) 
Wild-type 55 ± 3.8 127 ± 3.9 2.56 ± 0.16 2.62 ± 0.17 466 206 
E24Q 117 ± 8.0 463± 44 1.12 ± 0.07 1.13 ± 0.05 96 24 
S99A 1374 ± 96 176 ± 17 2.03 ± 0.22 1.95 ± 0.18 15 111 
T101A 98 ± 6.2 220 ± 14 2.13 ± 0.13 2.22 ± 0.17 218 101 
D103N 141 ± 13 184 ± 12 2.03 ± 0.21 2.15 ± 0.13 144 117 
D103A 163 ± 11 258 ± 18 1.88 ± 0.09 1.93 ± 0.12 116 75 
E132Q 1264 ± 152 144± 25 1.63 ± 0.08 1.55 ± 0.07 13 108 
E132A 1979 ± 213 198 ± 23 1.23 ± 0.10 1.16 ± 0.11 6 59 
T134A 87 ± 8.4 142 ± 16 2.05 ± 0.15 2.12 ± 0.15 236 149 
D135N 68± 5.6 273 ± 9.1 1.04 ± 0.11 0.96 ± 0.09 154 35 
S253A 76 ± 5.6 4698 ± 232 1.56 ± 0.14 1.72 ± 0.09 205 4 
S255A 74 ± 7.2 3708 ± 404 1.36 ± 0.17 1.43 ± 0.16 185 4 
a: kcat,ATP means apparent turnover numbers derived from variable ATP experiments. kcat,L-Thr 
means apparent turnover numbers derived from variable L-threonine experiments. Mean 
values of kcat and Km were used to calculate kcat/Km. Mutants without measurable ability 
(E24A, S100A and D135A) are not shown in this table. The values shown are based on three 
replicates. 
 136
0
0.05
0.1
0.15
0.2
-0.02 -0.01 0 0.01 0.02 0.03 0.04 0.05
1/[ATP] (1/uM)
1/
v
 
(m
in
 
m
g/
n
m
o
l)
[Thr] (uM)
50
100
200
500
 
0
0.05
0.1
0.15
0.2
-0.01 -0.005 0 0.005 0.01 0.015 0.02 0.025
1/[Thr] (1/uM)
1/
v
 
(m
in
 
m
g/
n
m
o
l)
[ATP] (uM)
      25
      50
     100
     500
 

 
 
Figure 4.1 Initial-rate study of the PduX reaction. Double reciprocal plots of rate versus 
substrate concentration with one substrate varied and the other held at a saturating level (ATP 
at 2 mM and L-theronine at 5 mM). The reaction conditions were as follows: PduX enzyme 
(10 nM), ATP and L-threonine concentration as indicated. Standard assay mixtures contained 
15 mM HEPES (pH 7.4), 20 mM NaCl, 10 mM MgCl2 in a total volume of 0.1 mL. The 
values shown are based on three replicates. 
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Figure 4.2 Kinetic analysis of product inhibition by L-Thr-P. A) L-Thr-P is a 
noncompetitive inhibitor of L-threonine in the PduX reaction. ATP concentration was held at 
2 mM. B) L-Thr-P is a noncompetitive inhibitor of ATP in the PduX reaction. L-threonine 
concentration was held at 5 mM. The reaction conditions were the same as stardard assay. 
The values shown are based on three replicates. 
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Figure 4.3 Kinetic analysis of dead-end inhibition by the ATP analog AMP-PNP. A) 
AMP-PNP is a noncompetitive inhibitor of L-threonine in the PduX reaction. ATP 
concentration was held at 2 mM. B) AMP-PNP is a competitive inhibitor of ATP in the PduX 
reaction. L-threonine concentration was held at 5 mM. The reaction conditions were the same 
as stardard assay. The values shown are based on three replicates. 
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Figure 4.4 Kinetic analysis of dead-end inhibition by the L-threonine analog L-valine. A) 
L-Val is a competitive inhibitor of L-threonine in the PduX reaction. ATP concentration was 
held at 100 µM. B) L-Val is an uncompetitive inhibitor of ATP in the PduX reaction. 
L-threonine concentration was held at 300 µM. The reaction conditions were the same as 
stardard assay. The values shown are based on three replicates. 
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Figure 4.5 The effects of pH on the kinetic parameters of the PduX enzyme. Three kinetic 
constants, kcat, kcat/Km,ATP, and kcat/Km,L-Thr, were determined over the pH range 5.5–9.0. 
Reactions were performed in the absence (solid circles) and presence (open diamond) of 20% 
(v/v) DMSO. (A) The pH effects on the apparent turnover number (kcat). Values for kcat were 
determined with variable L-threonine and variable ATP concentrations at each pH value with 
similar results. Average values are shown on the figure. (B) The pH effects on the apparent 
specificity constant of ATP (kcat/Km,ATP). (C) The pH effects on the apparent specificity 
constant of L-threonine (kcat/Km,L-Thr). The values shown are based on three replicates. 
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Figure 4.6 The effects of deuterium oxide on the kinetic parameters of the PduX enzyme. 
Three kinetic constants, kcat, kcat/Km,ATP, and kcat/Km,L-Thr, were determined at pH 8.0. (A) The 
kinetic isotope effect on the apparent turnover number (kcat). Values for kcat were derived 
from both variable L-threonine and variable ATP experiments at each D2O mole fraction and 
similar values were obtained. Average values are shown on the figure. (B) The isotope 
effects on the apparent specificity constant of ATP (solid circles), and the apparent 
specificity constant of L-threonine (open diamonds). The values shown are based on three 
replicates. 
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PduX Motif    I   II   IV   III 
GHMP Motif    I   II   none   III 
                                24               99           132             253 
           *          *** *   * **        * *  GeneBank number 
S. enterica   PASCGELIQG PVAKGMASSTADI IEPTDS GLNVAHSGSVVG   AAD39022 
C. freundii   PASCGELIQG PIAKGMASSTADI LEPTDS GVNVAHSGSVVG   CAM57303 
K. pneumoniae  PASCGELIQG PVAKGMASSTADI LEPTDS GLNVAHSGSVVG     YP_001336851 
P. luminescens  PASCGELIQG PMAKGLASSTADI LEPTDS GLNVAHSGSVVG   NP_930200 
Y. enterocolitica  PASCGELLQG PVAKGLASSTADI LEPTDS GLNVAHSGSVIG     YP_001008181 
L. welshimeri  PASCGELLQG PVAKGMASSTADI LEPTDS GINVSHSGTVVG   YP_849325 
A. metalliredigens PGSCGELIQG PMGKGMASSTADL IEPTDS GVNVAHSGTVMG     YP_001317970 
H. modesticaldum  PATCGELAQG PSGKGLATSTADI VEPSDG GVNVAHSGTVLG   ABZ84953 
T. carboxydivorans PGTCGELVQG PIGKGMASSSADI IEPTDG GVNVAHSGTVLG     ZP_01666223 
M. thermoacetica  PGACGELVQG PPGKGLASSTADV VEPSDG GVNTAHSGTVIG   YP_429960 
C. hydrogenoformans CGTAGELVQG PEGRGMGSSTADL VEPTDG GVNVAHSGSGIG   YP_359626 
N. thermophilus  PLTCGEWVQG PSAQGFGTSSADI IEPSDT GVIRAHSGTALG     ZP_02852581 
D. hafniense   PGTCGEWVQG LIGKGMASSTADM IEPSDP GVITAHSGTLLA     ZP_01372324 
B. pseudomallei  YCSFGELLQG PIGKGLSSSSADL IEPTDG GLVTAHSGTCIG   EDS87805 
A. friuliensis  FGTFGELLQG PEGKGLASSSADL IEPTDG GVVVGHSGTTLG   CAD32905 
S. sanguinis   PGSCGELFQG PISKGYSSSTADM IEPTDS GLNVAHSGTLVG     YP_001034508 
B. thuringiensis  CGTCGELVQG MEGKGMASSTADI IEPSDG GISVAHSGSILS     YP_001573827 
C. botulinum   PGSFGEILQG PRGKGLASSTADL IEPTDS GIIGCHSGDALG     YP_001253487 
 
Figure 4.7 Motifs found in a multiple sequence alignment of PduX homologues. A 
multiple sequence alignment identified four conserved motifs in PduX. The corresponding 
motif in the GHMP family is indicated. Motif four is characteristic of PduX. Motif I is only 
weakly conserved. Deduced amino acid sequences of 18 PduX homologues were aligned 
using the program ClustalX. Residue numbering corresponds to the PduX enzyme of 
Salmonella. Invariant residues were marked by stars. The abbreviations for organisms in 
sequence are Salmonella enterica, Citrobacter freundii, Klebsiella pneumoniae, 
Photorhabdus luminescens, Yersinia enterocolitica, Listeria welshimeri, Alkaliphilus 
metalliredigens, Heliobacterium modesticaldum, Thermosinus carboxydivorans, Moorella 
thermoacetica, Carboxydothermus hydrogenoformans, Natranaerobius thermophilus, 
Desulfitobacterium hafniense, Burkholderia pseudomallei, Actinoplanes friuliensis, 
Streptococcus sanguinis, Bacillus thuringiensis, Clostridium botulinum. 
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Figure 4.8 CD spectra of the PduX enzyme. CD spectra used in this study were collected 
using a Jasco J-710 spectropolarimeter (cell length = 1 cm). The sample contained PduX 
enzyme (4.0 µM), K2HPO4 (10 mM). CD data were collected from 190 to 250 nm with 
resolution 0.2 nm, band width 1.0 nm, sensitivity 20 mdeg and response 8 seconds at room 
temperature. CD data were analyzed by program JFIT. Solid line is experimental data, dot 
line is the fitted values and interval line indicates the error. 
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CHAPTER 5 SUMMARY AND GENERAL CONCLUSIONS 
This dissertation focuses on the kinetic and mutational analysis of enzymes involved in 
biosynthesis of coenzyme B12 especially for the upper and lower ligands. 
Chapter 2 is about the upper ligand (adenosyl group) formation. ATP:cob(I)alamin 
adenosyltransferase catalyzes the transfer of adenosyl group from ATP. No general study on 
the effects of mutations on hATR activity and function has been reported before. Therefore, 
we conducted a random mutagenesis of the hATR using Salmonella as a surrogate host to 
screen for changes in enzyme activity in vivo. 
1) Fifty-seven missense mutations at 30 positions were found to impair hATR 
activity in vivo in the surrogate host. These included mutations at 25 new sites 
that eliminate or reduce the hATR activity and hence could result in 
methylmalonyl aciduria if found in humans. 
2) We also used indicator plates with different amounts of OH-Cbl to view the 
sensitivity of the mutants to B12 concentration. Eleven mutants, G63E, D64G, 
R76G, K78R, G97R, G97E, S126L, H183Y, R215K, D218N, and R225K, had 
an increased level of color formation (ATR activity) at higher concentration of 
OH-Cbl indicating these residues are important to binding of MgATP/cobalamin 
by the hATR in vivo. 
3) The stability of the mutant hATR proteins in Salmonella was examined by 
western blotting. Mutant proteins C119Y, R186W, C189Y, R190C, and R191W 
were produced at much lower levels than the wild-type, indicating that these 
mutations impair proper protein folding leading to degradation by cellular 
proteases. 
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4) Kinetic constants were determined for the wild-type and mutant hATRs. Km and 
kcat values were determined by nonlinear regression with Grafit. Group I 
consisted of 19 mutants (K78Q, E84K, G87R, D90N, E91K, L92S, S94L, 
R186W, C189Y, R190C, R191W, E193K, R194G, F212S, R215K, S217R, 
L220P, L223P, and R225K) that had no activity even with a 10-fold excess of 
ATP and cob(I)alamin compared to the standard assay. Group II consisted of 
three mutants (R76G, F83S, and S126L) that exhibited relatively large changes 
in the Km values for both ATP and cob(I)alamin. Group III mutants (G63E, 
D64G, S68F, K78R, G97R, and D218N) showed modest changes or wild-type 
Km values for ATP and cob(I)alamin, but a substantially reduced Vmax. Group IV 
mutants (G97E, C119Y, T161I, and H183Y) had kinetic constants in the 
wild-type range. 
5) We used UV-visable spetra to determine the effect of mutations on AdoCbl 
Binding. S68F, K78Q, K78R, R186W, and R190C mediated blue shifts similar 
to that of the wild-type hATR. However, the majority of the hATR missense 
mutants lacked a measurable blue shift. 
6) We also used EPR spectra to determine the effect of mutation on cob(II)alamin 
binding. The results were consistence to those in UV-visible spectra study, only 
S68F, K78Q, K78R, R186W, and R190C exhibited EPR spectra indicating 
base-off binding of cob(II)alamin. 
Chapter 3 and 4 are related to the lower ligand (DMB) formation. Previous work 
proposed that PduX homologues might be L-threonine kinases involved in B12 synthesis. 
This was based sequence similarity to GHMP family of kinases and the observation that 
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pduX genes were proximal to B12 biosynthetic genes in several instances. However, there was 
no direct evidenence before. Here, we presented in vitro and in vivo evidence that the pduX 
gene of Salmonella enterica encodes an L-Thr kinase involved in the de novo synthesis 
AdoCbl and the assimilation of Cby. 
1) PduX is needed for Salmonella enterica growth on 1,2-PD minimal medium 
supplemented with Cby, but not on similar medium supplemented with Cbi. 
2) A Pdux deletion mutation is complemented by ectopic expression of Pdux. 
3) Supplementation of growth media with L-threonine-phosphate substantially 
corrects the growth defect of a PduX mutant. 
4) A bioassay and growth tests showed that a pduX deletion mutant was impaired 
for the de novo synthesis AdoCbl and for the assimilation of Cby. 
5) 31P NMR spectroscopy indicated that purified PduX-His6 catalyzes the 
conversion of ATP and L-Thr to ADP and L-Thr-P. And there are no other 
intermediate produced in the reaction. 
6) Enzyme assays indicated the ATP was preferred substrate for PduX compared to 
GTP, CTP and UTP. Based on nonlinear regression, the Km values for ATP and 
L-Thr were 54.7 ± 5.7 µM, and 146.1 ± 8.4 µM, respectively. The enzyme Vmax 
was 62.8 ± 3.6 nmol min-1 mg protein-1. 
7) Previous studies of GHMP family members have revealed three kinetic 
mechanisms, depending on the enzyme. The studies of PduX L-threonine kinase 
presented here are consistent with an ordered ternary complex mechanism in 
which ATP binds first and L-threonine second. 
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8) We also determined the effects of pH and deuterium oxide on the kinetic 
parameters of PduX. A small pH-dependent effect on the apparent turnover 
number was measured. Similarly, only a small kinetic isotope effect on kcat was 
observed with deuterium oxide. These indicate that there are no critical ionizable 
residues involved in the interaction of the free enzyme with ATP or in the 
interaction between the enzyme–ATP complex with L-threonine. It probably 
derives its catalytic power from its ability to stabilize the transition state. 
9) We conducted site-directed mutagenesis at several conserved residues among 
PduX homologues and GHMP family members. We used CD spectra to detect 
protein secondary structure changes caused by amino acid replacements. 
Mutations E24A and D135A resulted in a large decrease in helical structure 
indicating that these two conserved sites might be involved in proper folding of 
PduX enzyme. 
10) Kinetic constants were determined for the wild-type and mutant PduX enzymes. 
Three mutants (E24A, S100A and D135A) had no activity even with saturating 
levels of both substrates. Two of these (E24A and D135A) had abnormal CD 
spectra indicating improper folding. Six mutants (E24Q, T101A, D103A, 
D103N, T134A and D135N) had kinetic parameters similar to those of wild-type 
PduX. The remaining five mutants had altered kinetic properties compared to 
wild-type PduX. Mutations S253A and S255A increased the Km for L-threonine 
more than 30-fold indicating that these residues may be involved in binding of 
L-threonine. Mutations S99A, E132Q, and E132A, had Km values for ATP more 
than 20-fold higher than wild-type indicating a possible role in ATP binding. 
 148
ACKNOWLEDGEMENTS 
I would like to acknowledge many people for helping me during my doctoral work. I 
would especially like to thank my major professor, Dr. Bobik, for his generous time and 
commitment, for having faith and confidence in me. This dissertation would not have been 
possible without his expert guidance and support. I would also like to thank my POS 
committee members for their comments and suggestion: Dr. Alan Disprito, Dr. Alan Myers, 
Dr. Basil Nikolau and Dr. Anthony Pometto III. 
It has been a pleasure studies with my colleagues in Dr. Bobik’s lab: Shouqiang Cheng, 
Yu Liu, Huilin Zhu and David Gogerty for their help during my research in Iowa State 
University. 
Most importantly, I want to thank my family: my mother, Yumei Pan; my father, Youju 
Fan; and my girlfriend, Qinglei Gan, for their endless love. 
 
